Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3035062	maksa-1-is	u/l (u/l)	858	971	0.00%
3035062	afosmaksa1	u/l (u/l)	553	626	0.00%
3035062	s-afmaks1	u/l (—)	159	180	100.00%	Distribution not available
3035062	afosmaksa1	— (—)	142	149	100.00%	Distribution not available
3035062	s-maksa-1	u/l (u/l)	104	115	0.00%
3035062	s-maksa1	u/l (u/l)	70	70	0.00%
3035062	s-afos1ma	u/l (—)	67	76	100.00%	Distribution not available
3035062	maksa-1-is	— (—)	58	63	100.00%	Distribution not available
3035062	s-maksa-1-isoentsyymi	u/l (u/l)	21	21	0.00%	Distribution not available
3035062	maksa-1-ls	u/l (u/l)	18	22	0.00%
3035062	maksa-1-isoentsyymi	u/l (u/l)	14	14	0.00%
3035062	s-maksa-1	— (—)	6	6	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic kidney disease

285

437

6.61

175.61

1.2

1.1

101.51

88.65

u/l

0.82

246

324

Care involving dialysis

145

17.05

173.24

1.3

1.1

86.28

88.38

u/l

0.06

134

Dialysis, with operation codes

170

172

10.19

149.59

1.2

1.1

98.61

94.31

u/l

0.13

154

132

Renal failure

343

668

4.75

144.59

1.2

1.1

103.94

89.88

u/l

1.10

293

495

Diseases of liver

304

623

4.96

138.45

1.2

1.1

107.80

82.62

u/l

3.89

254

495

Nephropathy related operations

159

182

9.00

127.54

1.2

1.1

100.78

95.35

u/l

0.16

143

140

Anaemias

184

129

9.59

125.92

1.2

105.22

66.87

u/l

2.96

155

110

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

584

1376

3.06

123.59

1.2

1.1

99.56

80.36

u/l

3.28

479

1083

ILD medications: immunosuppressive drugs

406

1081

3.63

121.92

1.2

1.1

83.28

84.34

u/l

0.07

348

825

Extracorporeal dialysis

108

14.90

120.03

1.3

1.1

89.82

95.98

u/l

0.15

First line medication for Crohn's disease

623

1133

3.02

117.84

1.1

87.62

84.18

u/l

0.33

534

858

Secondary hypertension

117

12.07

114.92

1.3

1.1

104.90

74.74

u/l

1.20

107

GASTRO-related operations

400

502

4.02

109.95

1.2

1.1

82.46

75.44

u/l

0.65

342

307

Any gastric operation

400

502

4.02

109.95

1.2

1.1

82.46

75.44

u/l

0.65

342

307

Other diseases of liver

186

307

6.19

107.55

1.2

1.1

103.37

80.78

u/l

2.56

152

243

Renal tubulo-interstitial diseases

512

1331

2.97

104.94

1.2

1.1

100.71

81.43

u/l

2.94

420

1034

Autoimmune diseases excluding thyroid diseases

559

1047

2.98

104.36

1.1

86.29

83.19

u/l

0.31

468

821

Glomerular diseases

174

281

6.31

102.80

1.2

1.1

100.77

87.62

u/l

0.55

148

219

Preparatory care for dialysis

16.95

100.84

1.4

1.1

76.31

100.56

u/l

0.82

Autoimmune diseases excluding thyroid diseases, strict definition

537

1012

2.97

100.05

1.1

84.39

83.60

u/l

0.07

451

793

Glomerular disorders in diseases classified elsewhere

130

163

8.18

96.85

1.2

1.1

108.49

92.62

u/l

0.46

108

124

ILD medications

599

1219

2.71

94.58

1.1

88.98

84.05

u/l

0.52

513

928

Abnormal findings on examination of blood, without diagnosis

305

779

3.70

93.52

1.2

1.1

98.47

86.90

u/l

1.26

246

608

ILD medications: prednisolone, methylprednisolone, prednisone

582

1215

2.72

93.38

1.1

91.55

84.07

u/l

0.89

499

927

Other bacterial diseases

529

1336

2.75

92.19

1.2

1.1

97.15

82.52

u/l

2.42

435

1047

Autoimmune diseases related-to ILD

479

1510

2.81

92.09

1.1

82.04

86.89

u/l

0.50

404

1182

Transplanted organ and tissue status

110

130

8.68

86.02

1.3

1.1

96.27

87.77

u/l

0.30

102

Autoimmune diseases

554

1062

2.68

83.53

1.1

89.64

82.75

u/l

0.71

450

834

Dialysis

15.22

83.17

1.4

1.1

74.10

86.41

u/l

0.37

Inflammatory bowel disease treatment related agents

588

1330

2.52

81.93

1.1

88.03

84.53

u/l

0.34

494

1030

Insulin, fast-acting

240

622

3.89

80.77

1.2

1.1

114.66

82.35

u/l

2.32

184

489

Insulin, fast-acting or short human

240

638

3.80

77.92

1.2

1.1

114.66

85.34

u/l

1.97

184

508

Used for control exclusion in common control thyroid runs

504

960

2.67

75.74

1.1

90.08

83.20

u/l

0.63

413

758

Oral corticosteroids

537

1313

2.49

74.06

1.1

89.81

84.77

u/l

0.52

450

1023

Other dialysis

15.24

73.85

1.3

1.1

77.56

91.65

u/l

0.40

Bacterial infection, other or unspecified

305

870

3.19

73.76

1.2

1.1

104.19

84.68

u/l

1.90

258

667

Heart failure, not strict

415

1046

2.75

72.36

1.2

1.1

96.33

83.87

u/l

1.26

331

826

Kidney transplant status

12.02

70.78

1.3

1.1

85.53

87.63

u/l

0.05

Other septicaemia

226

609

3.68

69.75

1.2

1.1

103.37

84.64

u/l

1.95

190

462

Fever of other and unknown origin

301

919

3.06

68.45

1.2

1.1

106.08

81.56

u/l

2.33

259

728

Type 1 diabetes, wide definition, subgroup 1

147

296

5.02

68.42

1.2

1.1

122.06

79.47

u/l

1.98

108

240

Aplastic and other anaemias

271

802

3.23

67.92

1.2

1.1

103.60

87.74

u/l

1.39

227

608

Diabetic nephropathy, excluding more controls

137

207

5.63

67.40

1.2

1.1

110.12

94.75

u/l

0.46

109

168

Fibrosis and cirrhosis of liver

115

7.97

64.79

1.1

1.0

122.23

72.07

u/l

4.94

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

475

1341

2.42

63.94

1.2

1.1

87.37

84.54

u/l

0.24

385

1056

Malignant neoplasm of breast

322

801

2.93

63.43

1.2

1.1

74.05

83.83

u/l

1.49

282

618

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

235

557

3.46

62.82

1.2

1.1

73.88

77.97

u/l

0.38

211

424

Insulin, intermediate and long-acting

297

1013

2.90

62.22

1.2

1.1

113.85

82.83

u/l

2.93

231

792

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

294

624

3.11

62.15

1.2

1.1

72.81

77.63

u/l

0.57

258

479

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

294

624

3.10

62.15

1.2

1.1

72.81

77.63

u/l

0.57

258

479

Type 1 diabetes

162

382

4.28

62.05

1.2

1.1

113.74

81.52

u/l

1.61

120

305

Septicaemia

236

691

3.31

61.84

1.2

1.1

103.19

86.70

u/l

1.63

199

522

Malignant neoplasm

451

1085

2.48

61.55

1.2

1.1

87.66

85.05

u/l

0.20

376

850

Diabetic nephropathy

138

285

4.87

61.44

1.2

1.1

110.12

103.02

u/l

0.18

109

237

Type 1 diabetes, wide definition

148

329

4.54

61.17

1.2

1.1

122.88

78.82

u/l

2.12

109

265

L04AD Calcineurin inhibitors

102

163

6.39

61.06

1.3

1.1

97.69

83.46

u/l

0.60

131

Malignant neoplasm of breast, HER2-negative

313

802

2.89

60.78

1.2

1.1

74.27

83.82

u/l

1.41

276

617

Disorders of gallbladder, biliary tract and pancreas

497

1382

2.33

60.74

1.2

1.1

94.83

83.74

u/l

1.45

396

1101

Insulin, combination of fast acting with intermediate-acting or long-acting

322

1094

2.73

59.66

1.2

1.1

111.45

83.26

u/l

2.88

255

860

Insulin medication

322

1006

2.75

59.60

1.2

1.1

111.45

81.87

u/l

3.11

255

789

Abnormal serum enzyme levels

186

495

3.75

59.19

1.2

1.1

99.80

92.31

u/l

0.42

148

393

Acute renal failure

138

302

4.63

58.34

1.2

1.1

115.83

90.42

u/l

1.20

117

223

L02BG Aromatase inhibitors

211

627

3.41

58.23

1.2

1.1

73.33

82.41

u/l

1.02

191

479

Explicit Sepsis

242

747

3.13

57.83

1.2

1.1

102.51

82.72

u/l

2.56

204

574

Malignant neoplasm of breast, HER-positive

235

737

3.18

57.82

1.2

1.1

73.88

84.02

u/l

1.25

211

571

Second line medication for Crohn's disease

312

1164

2.70

57.50

1.2

1.1

77.82

86.67

u/l

0.97

271

922

Any reimbursement code in KELA

233

320

3.66

57.31

1.2

1.1

77.89

74.31

u/l

0.30

193

249

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

432

1053

2.44

56.95

1.2

1.1

87.93

83.38

u/l

0.39

357

829

Malignant neoplasm, wide definition for exclusion

432

1053

2.44

56.94

1.2

1.1

87.93

83.38

u/l

0.39

357

829

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

432

1053

2.44

56.94

1.2

1.1

87.93

83.38

u/l

0.39

357

829

Nonalcoholic fatty liver disease

139

6.61

55.73

1.2

1.1

86.51

76.48

u/l

0.67

113

Implicit Sepsis

364

1139

2.50

54.32

1.1

101.69

81.75

u/l

2.08

290

885

L04AA Selective immunosuppressants

155

393

3.99

54.11

1.2

1.1

86.46

85.80

u/l

0.03

134

302

Medicines for HER+ breast cancer

236

764

3.04

53.75

1.2

1.1

73.88

83.95

u/l

1.25

211

593

Disorders of other endocrine glands

244

814

2.97

53.66

1.2

1.1

95.71

83.45

u/l

0.70

185

649

Anaemia in chronic diseases classified elsewhere

16.93

53.30

1.3

1.0

91.28

102.00

u/l

0.18

Other and unspecified anaemias

231

738

3.05

53.03

1.1

108.92

88.55

u/l

1.69

194

563

Persons encountering health services in other circumstances

209

653

3.22

53.03

1.1

91.37

82.25

u/l

0.53

179

541

Other anaemias

233

750

3.02

52.52

1.2

1.1

108.15

88.63

u/l

1.60

196

572

Disorders of parathyroid gland

154

393

3.92

52.18

1.3

1.1

95.23

81.73

u/l

0.50

117

297

Primary biliary cholangitis (PBC)

15.84

51.46

1.1

1.0

123.87

94.95

u/l

0.85

IBD patients in KELA-register

145

368

3.98

50.53

1.1

74.92

89.64

u/l

0.78

130

290

Persons encountering health services for other counselling and medical advice, not elsewhere classified

505

1336

2.16

50.49

1.2

1.1

89.71

83.72

u/l

0.55

354

1102

Persons encountering health services in other circumstances, wide

545

1343

2.11

50.12

1.2

1.1

90.47

83.69

u/l

0.72

402

1108

Reimbursement for rheumatic diseases

310

1233

2.52

49.99

1.1

86.52

86.45

u/l

0.01

254

985

Any event in cancer register

430

1119

2.29

49.63

1.2

1.1

86.75

84.63

u/l

0.15

355

880

Bacterial Sepsis

237

726

2.92

49.56

1.1

109.91

84.58

u/l

2.05

189

548

L04AX Other immunosuppressants

294

1148

2.58

49.52

1.2

1.1

77.79

86.22

u/l

0.86

254

912

Implicit bacterial Sepsis

218

660

3.05

49.46

1.1

113.25

83.80

u/l

2.31

171

500

Hernia of abdominal wall, postoperative

168

5.59

49.02

1.2

1.1

102.39

90.31

u/l

0.25

Persons encountering health services for specific procedures and health care

491

1426

2.14

48.93

1.2

1.1

93.06

82.52

u/l

1.17

385

1143

Hyperparathyroidism

139

346

4.02

48.87

1.2

1.1

86.62

82.82

u/l

0.13

107

261

Sub-endpoint used in defining T1D endpoints

169

480

3.49

48.54

1.2

1.1

118.66

82.56

u/l

1.91

126

386

ILD medications: azathioprine

102

204

5.06

48.07

1.2

1.1

82.53

93.29

u/l

0.32

154

Inflammatory bowel disease, strict (require KELA)

145

384

3.81

47.63

1.1

74.92

90.19

u/l

0.84

130

304

Diseases of oesophagus, stomach and duodenum

490

1408

2.12

47.56

1.1

91.07

83.84

u/l

0.77

413

1099

Polyarthropathies

346

949

2.44

47.49

1.2

1.1

88.16

85.69

u/l

0.17

292

754

Noninfective enteritis and colitis

245

894

2.75

47.16

1.1

80.54

86.21

u/l

0.32

215

711

Azathioprine

102

212

4.87

45.98

1.2

1.1

82.53

89.86

u/l

0.21

164

Inflammatory bowel disease

180

565

3.21

45.50

1.1

75.72

85.99

u/l

0.65

162

447

5-aminosalicylic acid

127

319

4.02

44.94

1.1

78.70

85.75

u/l

0.25

111

243

General symptoms and signs

487

1154

2.12

44.89

1.1

94.50

82.47

u/l

1.27

393

917

Hypertensive diseases (excluding secondary)

270

575

2.74

44.81

1.2

1.1

83.44

73.24

u/l

0.97

214

487

Osteopathies and chondropathies

280

1074

2.49

43.43

1.2

1.1

96.75

84.90

u/l

0.75

230

851

Metabolic disorders

442

1302

2.12

42.96

1.2

1.1

97.44

81.41

u/l

2.04

344

1042

Condition for Implicit Sepsis (Organ dysfunction codes)

388

1288

2.20

42.94

1.1

98.75

82.95

u/l

1.58

309

1013

Complications of surgical and medical care, not elsewhere classified

445

1539

2.08

42.85

1.2

1.1

90.43

84.70

u/l

0.51

372

1210

Hypertensive diseases

376

942

2.27

42.09

1.2

1.1

91.23

79.04

u/l

1.21

295

776

Diabetic retinopathy, strict definition

132

307

3.83

41.94

1.2

1.1

108.65

102.98

u/l

0.16

100

258

Hypertension

375

942

2.26

41.71

1.2

1.1

91.04

79.04

u/l

1.17

294

776

Ulcer of lower limb, not elsewhere classified

210

4.68

41.70

1.2

1.1

139.59

93.39

u/l

1.34

156

Hypothyroidism and >3 levothyroxin purchases

112

132

4.90

41.37

1.2

114.14

66.69

u/l

1.70

111

Hypothyroidism, levothyroxine purchases

112

132

4.90

41.37

1.2

114.14

66.69

u/l

1.70

111

Hypothyroidism (congenital or acquired)

112

132

4.90

41.30

1.2

114.14

66.69

u/l

1.70

111

Ulcerative colitis

141

411

3.46

40.22

1.2

1.1

76.00

87.83

u/l

0.58

126

322

Heart failure and antihypertensive medication

143

255

3.73

40.21

1.2

1.1

116.27

78.56

u/l

1.82

108

207

Presence of other functional implants

285

833

2.44

39.65

1.2

1.1

85.63

90.54

u/l

0.41

228

643

Hypertension, essential

363

929

2.24

39.57

1.2

1.1

91.80

79.01

u/l

1.19

282

763

Insulin, fast-acting (human)

184

4.83

39.42

1.3

1.1

133.81

78.38

u/l

1.60

146

Heart failure,strict

242

683

2.57

37.84

1.2

1.1

105.52

86.56

u/l

1.26

183

525

Certain infectious and parasitic diseases

430

1043

2.07

37.43

1.1

93.99

80.22

u/l

1.74

360

818

Cholelithiasis, broad definition with cholecystitis

393

1304

2.07

37.17

1.1

85.02

83.89

u/l

0.10

309

1039

Oedema, not elsewhere classified

166

558

2.98

37.03

1.2

1.1

94.73

84.65

u/l

0.48

136

443

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

301

1249

2.24

36.98

1.2

1.1

97.93

85.87

u/l

1.14

258

969

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

108

282

3.87

36.32

1.2

1.1

66.64

90.16

u/l

2.49

229

Ulcerative colitis (strict definition, require KELA)

102

257

4.01

36.06

1.2

1.1

66.11

90.79

u/l

2.55

212

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

245

4.08

35.87

1.2

1.1

65.22

90.28

u/l

2.47

201

Abnormal results of function studies

127

5.52

35.82

1.2

1.1

108.69

76.39

u/l

1.44

Other diseases of blood and blood-forming organs, wide

130

396

3.31

34.69

1.2

1.1

104.72

87.89

u/l

1.02

106

308

Osteoporosis

149

469

3.06

34.38

1.1

92.39

84.44

u/l

0.31

122

349

Oxycodone

183

656

2.72

34.21

1.2

1.1

107.05

82.63

u/l

2.32

151

500

Cholelithiasis

375

1296

2.04

34.08

1.1

81.95

84.13

u/l

0.22

295

1032

General examination and investigation of persons without complaint and reported diagnosis

292

675

2.31

33.67

1.1

86.85

83.11

u/l

0.23

207

543

Cholangitis (primary sclerosing, PSC)

6.63

33.67

1.2

108.98

82.02

u/l

1.05

Gastro-oesophageal reflux disease

310

1289

2.14

33.63

1.1

87.93

84.57

u/l

0.21

268

1004

Unspecified kidney failure

120

5.49

33.62

1.1

91.26

95.85

u/l

0.10

Crohn disease

178

4.54

33.30

1.1

81.45

84.48

u/l

0.07

144

Finngen Rheumatological endpoints

403

1152

2.00

33.24

1.1

93.94

83.08

u/l

1.18

336

910

Influenza and pneumonia

439

1514

1.91

32.96

1.2

1.1

89.78

83.60

u/l

0.83

349

1212

Other retinal disorders

288

1056

2.20

32.89

1.2

1.1

104.92

84.95

u/l

1.69

222

827

Diseases of the skin and subcutaneous tissue

423

1074

1.98

32.82

1.1

87.05

83.62

u/l

0.28

351

829

Budesonide

197

4.31

32.72

1.2

1.1

86.43

83.75

u/l

0.09

150

Acute tubulo-interstitial nephritis

266

1059

2.24

32.28

1.2

1.1

88.67

81.10

u/l

0.78

210

818

Hypothyroidism, drug reimbursement

5.31

32.21

1.2

104.53

68.44

u/l

1.11

Other disorders of skin and subcutaneous tissue

314

1388

2.08

31.95

1.1

101.00

83.92

u/l

1.58

259

1095

Chronic periapical parodontitis

117

354

3.33

31.60

1.2

1.1

95.33

93.14

u/l

0.06

105

286

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

417

1325

1.93

31.56

1.1

101.33

80.45

u/l

2.87

338

1057

Other disorders of skin and subcutaneous tissue, not elsewhere classified

229

3.97

31.46

1.2

1.1

99.89

85.26

u/l

0.59

167

Complications of medical and surgical care

325

1521

2.04

31.41

1.1

95.44

83.91

u/l

0.92

283

1187

Disorders of thyroid, IBD co-morbidities

168

4.10

31.18

1.2

1.1

76.10

79.62

u/l

0.14

137

Diabetes mellitus

436

1379

1.89

31.08

1.1

101.05

79.69

u/l

3.16

354

1100

Hypothyroidism, strict autoimmune

294

902

2.17

30.96

1.2

1.1

88.13

82.90

u/l

0.33

232

712

Dentinal caries

119

367

3.25

30.86

1.2

1.1

98.22

92.26

u/l

0.18

101

296

Abnormalities of breathing

375

1124

1.99

30.80

1.1

87.41

83.55

u/l

0.38

295

894

Diabetes, varying definitions

434

1377

1.89

30.78

1.1

101.08

79.75

u/l

3.14

353

1098

387

1245

1.95

30.65

1.2

1.1

88.28

86.32

u/l

0.18

310

988

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

387

1245

1.95

30.65

1.2

1.1

88.28

86.32

u/l

0.18

310

988

Other heart diseases

214

572

2.48

30.62

1.2

1.1

102.36

73.50

u/l

2.38

178

484

Other disorders of fluid, electrolyte and acid-base balance

154

534

2.80

30.57

1.2

1.1

101.95

87.42

u/l

0.78

132

407

Ulcerative colitis, NAS

200

4.14

30.36

1.2

1.1

70.69

85.23

u/l

1.17

161

Nutritional anaemias

227

960

2.31

30.34

1.2

1.1

103.94

87.03

u/l

0.92

187

757

Type 2 diabetes, wide definition

355

1161

2.00

30.29

1.1

107.57

81.43

u/l

3.19

289

910

All pneumoniae

416

1529

1.88

30.21

1.2

1.1

91.87

84.02

u/l

1.01

330

1222

Pneumonia, organism unspecified

379

1421

1.94

30.14

1.2

1.1

91.14

84.75

u/l

0.72

300

1128

Pneumonias (Asthma/COPD co-morbidities)

411

1526

1.87

29.32

1.2

1.1

90.20

84.55

u/l

0.66

327

1221

Gout

132

404

3.00

29.30

1.1

104.43

95.84

u/l

0.28

113

297

Dermatitis and eczema

444

1595

1.83

29.21

1.2

1.1

86.75

85.28

u/l

0.13

367

1255

Diabetes, insulin treatment (Kela reimbursement)

429

1416

1.86

29.17

1.1

100.39

81.04

u/l

2.63

346

1132

Disorders of choroid and retina

349

1300

1.96

28.94

1.2

1.1

101.02

84.88

u/l

1.49

269

1026

Endocrine, nutritional and metabolic diseases

307

737

2.13

28.85

1.2

1.1

82.59

76.62

u/l

0.42

236

607

Implicit viral Sepsis

288

3.47

28.48

1.2

1.1

116.10

83.02

u/l

1.42

222

Diabetic retinopathy, excluding more controls

148

281

2.99

28.43

1.2

1.1

107.37

90.52

u/l

0.73

112

226

Viral Sepsis

290

3.44

28.19

1.2

1.1

116.10

83.00

u/l

1.42

224

Dental caries

124

412

3.00

28.13

1.2

1.1

97.17

91.47

u/l

0.18

106

333

Nausea and vomiting

128

430

2.95

28.07

1.2

1.1

108.17

84.37

u/l

0.90

110

340

Disorders of mineral metabolism

122

4.99

27.92

1.2

1.1

121.77

86.17

u/l

0.83

Gout, FINNGEN

132

463

2.87

27.72

1.1

104.43

97.73

u/l

0.21

113

349

Sleep disorders (combined)

414

1481

1.84

27.63

1.1

82.37

87.84

u/l

0.63

345

1165

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

116

5.08

27.51

1.2

1.1

90.62

78.52

u/l

0.82

Heart failure, strict

250

831

2.18

27.20

1.2

1.1

103.94

87.58

u/l

1.07

190

640

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

179

643

2.46

26.93

1.2

1.1

122.52

83.77

u/l

2.51

153

495

Diabetes medication

425

1426

1.82

26.91

1.1

100.44

79.76

u/l

2.98

347

1135

All-cause Heart Failure

246

822

2.17

26.52

1.2

1.1

103.98

87.80

u/l

1.04

188

633

Sleep apnoea

388

1432

1.84

26.38

1.1

80.66

88.96

u/l

1.22

320

1130

Sleep apnoea, including avohilmo

405

1446

1.82

26.33

1.1

79.68

89.01

u/l

1.53

337

1140

Other heart diseases, wide

378

1258

1.87

26.32

1.2

1.1

95.21

80.21

u/l

1.66

310

1006

Diseases of pulp and periapical tissues

163

655

2.50

26.19

1.2

1.1

92.37

91.49

u/l

0.03

144

533

Iron deficiency anaemia

189

809

2.33

25.79

1.2

1.1

105.74

86.44

u/l

0.89

158

638

Disorders of lens

302

955

2.00

25.75

1.2

1.1

95.58

84.75

u/l

0.78

243

742

Ulcerative colitis (strict definition, all Crohn cases excluded)

203

3.83

25.67

1.2

1.1

68.77

91.63

u/l

1.56

163

Complications of procedures, not elsewhere classified

330

1511

1.89

25.56

1.1

85.06

84.94

u/l

0.01

272

1185

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

7.41

25.50

1.2

1.1

147.26

93.40

u/l

0.81

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

394

1534

1.81

25.47

1.2

1.1

90.81

84.75

u/l

0.71

314

1226

Cardiovascular diseases (excluding rheumatic etc)

245

651

2.18

25.46

1.2

1.1

84.00

71.78

u/l

1.15

197

546

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

266

1319

2.02

25.38

1.1

97.29

84.99

u/l

0.83

228

1025

Mucosal proctocolitis

166

4.13

25.21

1.2

1.1

72.38

84.05

u/l

0.68

134

Opioids

399

1148

1.83

25.01

1.2

1.1

91.09

78.59

u/l

1.49

324

896

Other disorders of kidney and ureter

198

3.83

25.00

1.3

1.1

81.78

88.55

u/l

0.28

152

Amputation

138

4.47

24.96

1.2

1.1

158.94

86.17

u/l

1.39

104

Other diseases of intestines

418

1364

1.79

24.85

1.2

1.1

88.04

85.16

u/l

0.22

354

1071

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

236

3.55

24.82

1.1

118.84

93.08

u/l

1.02

184

Glomerulonephritis

147

4.34

24.81

1.2

1.1

81.43

81.91

u/l

0.02

113

Type 2 diabetes

404

1337

1.80

24.73

1.1

97.81

80.41

u/l

2.38

331

1064

Gout, strict definition

263

3.38

24.36

1.1

98.10

98.16

u/l

0.00

202

Other noninfective gastroenteritis and colitis

118

419

2.83

24.25

1.2

1.1

80.76

86.58

u/l

0.21

324

Diabetic retinopathy

171

442

2.46

23.79

1.2

1.1

103.83

98.52

u/l

0.19

129

359

Disorders of the thyroid gland

381

1389

1.80

23.79

1.1

89.14

84.44

u/l

0.30

295

1123

Erysipelas

219

944

2.12

23.71

1.1

92.53

83.11

u/l

0.85

175

722

Peripheral artery operations in Hilmo

188

3.81

23.55

1.2

1.1

156.83

86.84

u/l

1.67

136

Benzodiazepine use

398

1615

1.76

23.49

1.2

1.1

85.47

85.75

u/l

0.02

323

1280

Bleeding

337

1331

1.85

23.49

1.2

1.1

96.48

86.59

u/l

0.86

260

1057

Other soft tissue disorders, not elsewhere classified

359

1218

1.83

23.29

1.2

1.1

84.75

85.86

u/l

0.07

294

966

Osteomyelitis

5.38

22.80

1.2

1.1

167.71

97.68

u/l

1.14

Agranulocytosis

184

3.79

22.71

1.2

1.1

96.70

79.53

u/l

0.77

139

Disorders of calcium metabolism

5.14

22.62

1.1

133.89

77.24

u/l

1.13

Tramadol

317

1090

1.87

22.57

1.1

99.04

79.07

u/l

2.21

254

854

Vitreous haemorrhage

154

4.07

22.53

1.3

1.1

102.93

91.38

u/l

0.34

115

Cirrhosis of liver, NAS

5.81

22.47

1.1

128.16

76.42

u/l

2.24

Other and unspecified iron deficiency

146

601

2.44

22.35

1.1

107.35

85.46

u/l

0.79

121

468

Noninfectious colitis NAS

196

3.65

22.21

1.2

1.1

86.60

83.17

u/l

0.07

150

Dermatitis

252

1295

1.95

22.05

1.2

1.1

93.71

85.85

u/l

0.61

207

1023

Amputation of toe

103

4.83

22.00

1.2

1.1

169.56

85.01

u/l

1.26

Other and unspecified disorders of skin and subcutaneous tissue

5.07

21.87

1.3

1.1

93.46

83.54

u/l

0.31

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

245

1257

1.96

21.53

1.1

95.83

85.64

u/l

0.59

209

988

Chronic pancreatitis

173

3.79

21.46

1.1

1.2

119.42

97.43

u/l

0.56

136

Diseases of arteries, arterioles and capillaries (FINNGEN)

117

295

2.79

21.45

1.2

1.1

148.62

73.14

u/l

3.46

246

Constipation

356

1450

1.76

21.31

1.1

80.92

87.60

u/l

0.67

282

1151

Other and unspecified dermatitis

214

1057

2.03

21.00

1.2

1.1

89.79

85.68

u/l

0.32

178

845

Hyperkalaemia

5.49

20.75

1.2

1.1

129.87

93.17

u/l

0.53

Neoplasms

255

691

1.98

20.49

1.2

1.1

95.27

79.26

u/l

1.16

213

539

Gastrointestinal diseases

210

490

2.15

20.49

1.2

1.1

77.40

79.15

u/l

0.12

177

360

Hydronephrosis

135

4.11

20.31

1.1

111.28

83.23

u/l

0.70

100

Dyspnoea

350

1546

1.74

20.24

1.1

88.52

85.84

u/l

0.24

272

1235

Systemic connective tissue disorders

160

717

2.24

20.23

1.1

88.91

84.48

u/l

0.27

130

570

Pain in limb

301

1198

1.82

20.16

1.2

1.1

80.69

85.95

u/l

0.41

241

952

Diseases of the digestive system

187

891

2.10

20.11

1.2

1.1

102.07

88.36

u/l

0.64

144

695

Gout, unspecified

312

2.94

20.08

1.1

103.49

98.07

u/l

0.13

238

Gout, idiopatic and unspecified

107

403

2.67

19.79

1.1

104.18

96.45

u/l

0.22

312

Diarrhoea and gastroenteritis of presumed infectious origin

268

1318

1.85

19.76

1.2

1.1

97.66

83.30

u/l

1.35

214

1040

Hypothyroidism, other/unspecified

349

1327

1.74

19.71

1.1

89.01

84.40

u/l

0.28

274

1075

Parasetamol

284

773

1.88

19.37

1.2

88.42

82.56

u/l

0.36

223

621

Infections of the skin and subcutaneous tissue

220

1128

1.95

19.21

1.2

1.1

98.90

85.30

u/l

0.75

180

890

Symptoms and signs involving the digestive system and abdomen

384

1130

1.71

19.03

1.1

92.01

84.13

u/l

0.66

313

887

Cardiac arrhythmias

238

813

1.94

18.99

1.1

88.39

74.40

u/l

1.29

191

664

Diseases of peritoneum

169

3.59

18.31

1.2

1.1

75.28

81.41

u/l

0.33

130

Osteoporosis with pathological fracture (FG)

103

4.43

18.26

1.2

1.1

115.80

92.27

u/l

0.33

Fall on same level

432

1494

1.62

18.04

1.2

1.1

92.81

82.71

u/l

1.14

350

1182

Atrial fibrillation and flutter

140

391

2.35

17.99

1.1

98.54

73.93

u/l

1.42

109

332

Vocal cord dysfunction

170

3.46

17.97

1.1

92.83

74.61

u/l

0.37

138

COPD/asthma related infections

409

1247

1.65

17.78

1.2

1.1

81.18

86.32

u/l

0.67

332

988

COPD/asthma/ILD related infections

409

1247

1.65

17.78

1.2

1.1

81.18

86.32

u/l

0.67

332

988

Other medical care

160

737

2.13

17.78

1.1

100.85

88.02

u/l

0.52

111

571

Chronic ulcer of skin, not elsewhere classified

4.66

17.74

1.1

118.87

94.80

u/l

0.43

Deposits [accretions] on teeth

4.61

17.74

1.2

1.1

91.35

91.45

u/l

0.00

Hypothyreosis and Thyroxine purchase for inclusion criteria

358

1413

1.68

17.72

1.1

88.74

84.05

u/l

0.30

280

1137

Other disorders of urethra and urinary system

286

1212

1.77

17.72

1.2

1.1

77.35

87.12

u/l

1.36

222

983

Sulfasalazine

123

524

2.36

17.58

1.1

76.18

86.53

u/l

0.88

101

412

Medical observation and evaluation for suspected diseases and conditions

249

675

1.89

17.46

1.2

1.1

90.57

83.11

u/l

0.48

211

543

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

372

2.62

17.37

1.2

1.1

116.50

85.45

u/l

1.08

285

Senile cataract

256

864

1.84

17.31

1.2

1.1

90.69

85.34

u/l

0.28

208

669

Exposure to unspecified factor

357

1680

1.65

17.28

1.1

96.50

83.01

u/l

1.26

290

1331

Antihypertensive medication - note that there are other indications

201

545

2.02

17.26

1.2

1.1

76.27

75.50

u/l

0.06

161

441

Follow-up examination after treatment for conditions other than malignant neoplasms

181

575

2.07

17.24

1.2

1.1

74.38

83.10

u/l

1.20

158

464

Other disorders of teeth and supporting structures

369

2.62

17.12

1.1

104.90

89.14

u/l

0.52

296

Infections, IBD-co-morbidities

149

3.29

16.55

1.1

109.33

83.17

u/l

0.82

121

Obesity due to excess calories

182

927

1.97

16.52

1.1

79.84

85.95

u/l

0.61

147

749

Other special examinations and investigations of persons without complaint or reported diagnosis

247

675

1.86

16.30

1.1

96.74

83.11

u/l

0.84

194

543

Malaise and fatigue

182

768

1.98

16.26

1.1

92.94

83.52

u/l

0.65

150

607

Spondyloarthritis

255

2.92

16.25

1.1

86.54

93.21

u/l

0.21

196

Codeine

345

1140

1.67

16.14

1.2

1.1

84.21

78.62

u/l

0.52

285

891

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

127

265

2.41

16.09

1.1

83.02

74.86

u/l

0.52

101

219

Symptoms and signs involving the circulatory and respiratory systems

369

1129

1.64

15.97

1.1

83.88

83.53

u/l

0.02

299

898

Seropositive rheumatoid arthritis

112

479

2.34

15.83

1.1

81.10

85.25

u/l

0.27

376

Other diseases of biliary tract

124

3.83

15.81

1.3

1.1

102.90

87.14

u/l

0.49

Cerebrovascular diseases (FINNGEN)

131

418

2.25

15.74

1.1

116.88

73.35

u/l

2.30

353

Intestinal infectious diseases

341

1631

1.63

15.74

1.1

101.26

82.50

u/l

1.86

273

1292

Complications of internal orthopaedic prosthetic devices, implants and grafts

103

427

2.43

15.72

1.2

1.1

94.65

88.98

u/l

0.17

313

Biological medication for rheuma

250

2.90

15.63

1.2

1.1

73.89

85.59

u/l

0.57

208

Other and unspecified polyneuropathies, also in other diseases

324

2.64

15.47

1.2

1.1

131.27

87.46

u/l

1.15

250

Other diseases of pancreas

100

4.15

15.36

1.1

1.2

125.53

86.75

u/l

0.75

Hypothyroidism, strict autoimmune, 3 medication purchases required

322

1331

1.65

15.34

1.2

1.1

90.42

84.21

u/l

0.44

252

1078

Primary_lymphoid and hematopoietic malignant neoplasms

378

2.50

15.30

1.1

110.59

85.58

u/l

1.67

290

Abnormal findings on diagnostic imaging of lung

184

940

1.91

15.28

1.2

1.1

101.81

85.63

u/l

1.20

160

719

Continuous positive airway pressure

239

2.79

15.13

1.1

83.91

76.82

u/l

0.46

197

Diseases of the ear and mastoid process

429

1395

1.56

15.11

1.1

87.25

83.97

u/l

0.30

365

1091

Pain in throat and chest

302

1099

1.68

15.06

1.1

89.00

84.16

u/l

0.32

248

874

Drug-induced neutropenia

120

3.80

14.95

1.2

1.1

102.54

80.02

u/l

0.68

Other diseases of urinary system

385

1370

1.58

14.87

1.2

1.1

79.74

86.79

u/l

0.91

291

1106

Pure hypercholesterolaemia

273

1071

1.71

14.84

1.1

106.25

83.30

u/l

1.90

213

845

Other functional intestinal disorders

176

875

1.92

14.79

1.1

80.28

88.14

u/l

0.42

138

683

Rheumatoid arthritis

141

618

2.08

14.71

1.1

80.35

88.07

u/l

0.73

110

495

Abdominal and pelvic pain

361

1130

1.61

14.51

1.1

87.02

84.13

u/l

0.19

283

887

Cardiovascular diseases

194

552

1.92

14.48

1.2

1.1

78.81

71.98

u/l

0.74

154

457

Cellulitis

353

2.51

14.45

1.2

1.1

111.49

86.30

u/l

0.85

271

Other diseases of pleura

172

794

1.93

14.39

1.1

109.97

87.44

u/l

2.09

133

609

Other nutritional deficiencies

238

1346

1.73

14.37

1.1

79.59

84.70

u/l

0.61

194

1079

Disorders of lipoprotein metabolism and other lipidaemias

305

1165

1.65

14.22

1.2

1.1

103.30

82.71

u/l

1.88

231

922

Heart failure and bmi 25plus

142

470

2.09

14.17

1.1

100.40

80.20

u/l

1.15

109

391

Symptoms and signs concerning food and fluid intake

134

3.53

14.12

1.0

1.1

86.34

78.73

u/l

0.30

104

Episodal and paroxysmal disorders

399

1318

1.55

13.95

1.1

88.09

86.28

u/l

0.13

326

1045

Depression medications

142

2.84

13.90

1.2

80.55

66.81

u/l

1.39

119

Cholecystectomy

273

1459

1.66

13.83

1.1

79.73

88.85

u/l

1.17

220

1158

Hyperlipidaemia, other/unspecified

147

700

2.00

13.79

1.2

1.1

93.82

83.66

u/l

0.44

108

533

Cutaneous abscess, furuncle and carbuncle

422

2.33

13.79

1.2

1.1

98.27

84.76

u/l

0.44

332

Tumor necrosis factor alpha inhibitors

213

2.93

13.77

1.2

1.1

71.91

78.43

u/l

0.31

181

Benign neoplasm of colon, rectum, anus and anal canal

188

723

1.86

13.69

1.1

92.28

82.34

u/l

0.86

159

553

Purpura and other haemorrhagic conditions

210

2.93

13.51

1.2

1.1

89.20

90.54

u/l

0.05

161

Hypo-osmolality and hyponatraemia

293

2.60

13.49

1.3

1.1

107.81

91.08

u/l

0.44

225

Polyneuropathies and other disorders of the peripheral nervous system

373

2.40

13.34

1.2

1.1

128.14

85.67

u/l

1.20

290

Iron deficiency anaemia secondary to blood loss (chronic)

267

2.68

13.33

1.2

1.1

97.56

86.53

u/l

0.43

204

Psoriasis

117

552

2.13

13.21

1.1

81.80

86.77

u/l

0.20

436

Exclusions for E4_PCOS_BROAD

263

2.68

13.15

1.2

1.1

106.55

86.61

u/l

0.43

208

Fitting and adjustment of other devices

132

606

2.03

13.06

1.1

101.06

91.87

u/l

0.33

464

Symptoms and signs involving the urinary system

279

1325

1.63

13.00

1.1

94.51

84.52

u/l

0.83

224

1043

Obesity and other hyperalimentation

225

1307

1.71

13.00

1.1

81.49

83.84

u/l

0.22

187

1051

Coagulation defects, purpura and other haemorrhagic conditions

319

2.49

12.85

1.2

1.1

95.32

88.53

u/l

0.24

249

Familial hypercholesterolemia, with ischemic heart disease

148

3.27

12.84

1.2

1.1

126.78

89.28

u/l

0.65

110

Other systemic involvement of connective tissue (FG)

102

458

2.22

12.82

1.1

91.24

83.89

u/l

0.33

356

Glucagon-like peptide-1 (GLP-1) analogues

214

1016

1.74

12.77

1.1

91.04

85.66

u/l

0.34

181

792

Chronic periodontitis

256

2.67

12.77

1.3

1.1

92.56

93.44

u/l

0.02

203

Corns and callosities

3.95

12.71

1.4

1.1

129.56

86.54

u/l

0.51

Other cataract

167

691

1.88

12.70

1.2

1.1

98.36

86.75

u/l

0.55

133

529

Obesity

223

1302

1.70

12.69

1.1

81.37

83.94

u/l

0.25

186

1047

Benign neoplasms

229

748

1.74

12.64

1.2

1.1

102.60

80.66

u/l

1.62

187

583

Other diseases of the digestive system

120

583

2.07

12.56

1.2

1.1

100.50

92.82

u/l

0.25

455

Gonarthrosis [arthrosis of knee](FG)

276

993

1.64

12.48

1.1

85.83

85.43

u/l

0.02

217

780

Postmenopausal osteoporosis with pathological fracture

3.98

12.46

1.3

1.1

125.84

69.76

u/l

0.74

Ascites

3.87

12.35

1.3

1.1

193.50

82.13

u/l

1.85

Diabetic neuropathy

215

2.80

12.26

1.2

1.1

151.30

95.45

u/l

1.02

182

Syncope and collapse

153

719

1.89

12.21

1.1

97.58

83.06

u/l

0.61

119

563

Diseases of the eye and adnexa

282

866

1.63

12.14

1.1

88.93

81.05

u/l

0.51

230

702

AV-block

247

2.59

12.10

1.1

105.82

89.62

u/l

0.75

186

Pain in joint

208

793

1.74

12.02

1.2

1.1

76.16

85.18

u/l

1.20

169

631

Cough

155

801

1.86

11.98

1.1

76.87

88.50

u/l

1.19

132

636

Diseases of oral cavity, salivary glands and jaws

330

1085

1.56

11.93

1.1

84.72

87.90

u/l

0.19

253

872

Other inflammatory liver diseases

3.84

11.91

1.2

1.1

102.57

72.95

u/l

1.43

Peripheral artery disease

166

731

1.83

11.85

1.2

1.1

122.24

85.94

u/l

1.98

133

550

Other diseases of hard tissues of teeth

228

1015

1.68

11.85

1.1

80.17

86.79

u/l

0.65

181

814

Benign neoplasm: Colon

164

683

1.85

11.84

1.2

1.1

92.55

83.54

u/l

0.66

142

517

Atrial fibrillation and flutter with reimbursement

106

311

2.19

11.80

1.1

85.30

73.86

u/l

1.03

259

Enterocolitis due to Clostridium difficile

156

3.10

11.80

1.1

107.03

89.65

u/l

0.44

112

Gout due to impairment of renal function

9.69

11.73

1.2

73.79

111.10

u/l

—

Excluding asthma or asthma-COPD overlap

288

898

1.61

11.71

1.2

1.1

82.20

84.48

u/l

0.19

241

686

Valvular heart disease excluding rheumatic fever

170

684

1.82

11.67

1.2

1.1

110.09

81.62

u/l

2.07

138

527

Nerve, nerve root and plexus disorders

377

1586

1.50

11.66

1.2

1.1

88.37

84.92

u/l

0.27

306

1262

Intracranial trauma

193

826

1.75

11.66

1.1

86.31

83.22

u/l

0.13

144

669

Diseases of arteries, arterioles and capillaries

237

1072

1.65

11.64

1.2

1.1

120.46

82.36

u/l

2.97

197

825

Unspecified urinary incontinence

168

3.01

11.63

1.1

78.91

73.85

u/l

0.23

128

Thyrotoxicosis, other and/or unspecified

360

2.32

11.57

1.1

65.58

80.82

u/l

2.22

281

Non-rheumatic valve diseases

169

680

1.82

11.56

1.2

1.1

108.54

81.59

u/l

1.91

137

523

All influenza

404

2.24

11.56

1.2

1.1

95.23

87.73

u/l

0.32

313

Codeine or tramadol medication

404

1518

1.48

11.45

1.2

1.1

83.65

85.85

u/l

0.18

329

1197

Other antidepressants

369

1279

1.51

11.43

1.1

81.99

87.96

u/l

0.68

293

1021

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

161

553

1.85

11.32

1.2

1.1

88.19

73.76

u/l

1.62

131

469

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

101

3.30

11.30

1.2

1.1

93.83

85.49

u/l

0.21

Injuries to the hip and thigh

164

837

1.80

11.27

1.2

1.1

109.07

86.44

u/l

0.99

131

655

Non-ischemic cardiomyopathy

115

465

2.04

11.25

1.1

84.11

86.47

u/l

0.13

351

Recurrent or chronic depression

152

592

1.86

11.16

1.2

1.1

89.82

82.98

u/l

0.33

122

491

Other specific joint derangements/joint disorders

240

985

1.64

11.14

1.2

1.1

80.17

84.38

u/l

0.38

202

784

Papulosquamous disorders

149

815

1.83

11.09

1.1

84.68

87.51

u/l

0.13

122

647

Hypokalaemia

184

2.85

11.04

1.2

1.1

94.47

92.09

u/l

0.06

140

Intestinal stricture

117

592

1.98

11.02

1.2

1.1

110.50

88.82

u/l

0.79

461

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

255

2.24

10.99

1.2

1.1

69.72

92.46

u/l

2.04

203

Hard cardiovascular diseases

286

1175

1.57

10.96

1.1

121.55

81.22

u/l

3.79

217

955

Gastroduodenal ulcer

458

2.12

10.94

1.1

108.48

93.38

u/l

0.69

335

Other pulmonary diagnosis

283

898

1.58

10.76

1.2

1.1

81.28

84.48

u/l

0.28

236

686

Chronic periodontitis, complicated

149

3.05

10.76

1.4

1.1

81.35

97.31

u/l

0.69

120

Primary_lymphoid and hematopoietic malignant neoplasms

443

2.13

10.75

1.1

110.59

91.71

u/l

1.09

343

Other reaction to severe stress, and adjustment disorders

131

695

1.89

10.74

1.2

1.1

110.69

80.23

u/l

1.49

103

560

Irritable bowel syndrome

107

530

2.03

10.71

1.1

69.76

83.58

u/l

1.82

419

Disorders of vitreous body

189

1097

1.69

10.62

1.2

1.1

92.08

88.34

u/l

0.21

148

865

COPD differential diagnosis

282

898

1.58

10.57

1.2

1.1

81.56

84.53

u/l

0.25

234

688

ILD differential diagnosis

282

898

1.58

10.57

1.2

1.1

81.56

84.53

u/l

0.25

234

688

Thyroiditis, ILD-related definition

172

2.87

10.57

1.2

1.1

83.29

79.76

u/l

0.08

132

Mycoses

101

493

2.06

10.54

1.1

111.33

88.48

u/l

1.01

386

Rheumatoid arthritis, including avohilmo

150

836

1.80

10.53

1.1

82.14

87.76

u/l

0.51

117

665

Disorders of vitreous body and globe

193

1125

1.68

10.52

1.2

1.1

91.48

87.87

u/l

0.20

152

887

Neurological diseases, wide definition

200

2.29

10.52

1.2

1.1

74.01

83.19

u/l

0.50

164

Enlarged lymph nodes

241

2.54

10.46

1.1

99.26

81.65

u/l

0.85

196

Chronic laryngitis and laryngotracheitis

259

2.49

10.45

1.2

1.1

94.30

86.70

u/l

0.16

204

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

270

2.18

10.45

1.2

1.1

68.90

92.50

u/l

2.31

216

GI-bleeding

113

577

1.97

10.39

1.2

1.1

103.44

93.06

u/l

0.33

448

Mood disorders, excluding more controls

333

1355

1.50

10.38

1.1

85.74

82.41

u/l

0.24

251

1094

Other/unspecified seropositive rheumatoid arthritis

112

571

1.97

10.37

1.1

81.10

85.04

u/l

0.28

445

Falls/tendency to fall

386

1322

1.46

10.34

1.1

90.21

82.26

u/l

0.72

303

1056

407

1490

1.44

10.29

1.2

1.1

85.45

85.61

u/l

0.01

326

1183

Exposure to other specified factors

248

1485

1.57

10.28

1.1

88.41

84.51

u/l

0.22

201

1184

Viral infections characterized by skin and mucous membrane lesions

144

799

1.81

10.24

1.2

1.1

89.31

88.47

u/l

0.04

119

638

Fracture of femur

422

2.09

10.23

1.1

114.74

89.15

u/l

0.65

320

Paralytic ileus and intestinal obstruction

465

2.07

10.23

1.2

1.1

114.29

89.71

u/l

0.70

348

Diseases of the respiratory system

247

769

1.61

10.20

1.1

81.88

89.29

u/l

0.67

203

592

Familial hypercholesterolemia

263

2.45

10.13

1.2

1.1

129.17

90.29

u/l

0.86

200

Other arthritis (FG)

110

562

1.96

10.12

1.1

94.88

85.87

u/l

0.30

446

Myeloproliferative diseases

139

3.05

10.07

1.1

118.84

83.38

u/l

1.53

102

Seropositive rheumatoid arthritis, wide

112

577

1.95

10.07

1.1

81.10

84.79

u/l

0.26

449

Acute pancreatitis

313

2.31

10.05

1.1

111.82

89.91

u/l

0.44

245

Benign neoplasm of other and ill-defined parts of digestive system

283

2.38

9.99

1.1

89.20

84.34

u/l

0.25

213

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

109

3.33

9.98

1.3

1.1

106.27

83.91

u/l

0.78

Anxiety disorders, excluding more controls

286

1243

1.53

9.98

1.2

1.1

96.13

81.74

u/l

1.12

229

1005

Zoster [herpes zoster]

327

2.28

9.95

1.2

1.1

87.17

89.12

u/l

0.06

247

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

109

559

1.96

9.94

1.1

79.96

84.79

u/l

0.35

436

Type 2 diabetes, definitions combined, including avohilmo

325

1291

1.49

9.94

1.1

90.48

82.67

u/l

0.76

273

1031

Other systemic involvement of connective tissue

104

525

1.99

9.92

1.1

92.78

84.78

u/l

0.37

407

Myeloproliferative diseases (CML excluded)

125

3.15

9.88

1.1

125.53

86.31

u/l

1.59

Cholecystitis

207

2.62

9.87

1.1

102.54

90.56

u/l

0.32

155

Sequelae with surgical and medical care as external cause

373

2.18

9.87

1.3

1.1

82.91

88.44

u/l

0.30

285

Asthma, excluding more controls

248

833

1.59

9.83

1.1

79.41

81.64

u/l

0.18

193

642

Sequelae of external causes of morbidity and mortality

466

2.05

9.82

1.3

1.1

96.95

87.76

u/l

0.31

359

Family history of malignant neoplasm

164

2.82

9.67

1.2

1.1

69.95

76.92

u/l

0.45

133

Persons encountering health services for examination and investigation

220

675

1.64

9.67

1.1

90.90

83.11

u/l

0.47

174

543

Other disorders of ear

324

1463

1.48

9.67

1.1

85.85

86.49

u/l

0.04

269

1147

Smoking dependency

132

3.06

9.65

1.1

86.85

83.05

u/l

0.13

101

Mental and behavioural disorders due to tobacco

132

3.06

9.65

1.1

86.85

81.23

u/l

0.21

101

Gastric ulcer

300

2.31

9.64

1.1

113.39

93.88

u/l

0.68

218

Dental caries 3 and operation codes

314

1074

1.50

9.63

1.1

86.47

85.90

u/l

0.03

247

856

Any mental disorder

396

1383

1.44

9.62

1.2

1.1

93.35

82.20

u/l

1.07

310

1112

Depression

324

1515

1.47

9.62

1.1

85.85

85.29

u/l

0.03

240

1227

Other symptoms and signs involving the nervous and musculoskeletal systems

151

867

1.75

9.61

1.1

90.15

86.00

u/l

0.12

714

Collagenous colitis

138

2.99

9.57

1.1

80.95

79.60

u/l

0.05

103

Dental caries 1 and operation codes

301

1022

1.51

9.55

1.1

87.66

86.23

u/l

0.08

235

818

Statin medication

257

926

1.56

9.51

1.1

84.62

81.73

u/l

0.18

204

764

Other (not insulin) diabetes medications

332

1363

1.47

9.50

1.1

90.32

80.95

u/l

1.11

276

1086

Certain disorders involving the immune mechanism

353

2.19

9.50

1.1

103.50

87.04

u/l

0.71

281

malignant neoplasm of male genital organs

126

427

1.88

9.37

1.2

1.1

77.14

102.69

u/l

1.98

346

Other disorders of white blood cells

3.52

9.35

1.1

112.85

85.16

u/l

0.84

Presence of cardiac and vascular implants and grafts

146

625

1.77

9.35

1.2

1.1

115.31

91.26

u/l

1.23

115

471

Other disorders of adrenal gland

3.99

9.33

1.1

1.2

91.55

85.53

u/l

0.13

Other bacterial intestinal infections

286

2.32

9.31

1.1

92.25

87.23

u/l

0.14

219

Non-invasive ventilation

303

2.24

9.28

1.1

99.73

76.18

u/l

1.15

251

Vitamin B12 deficiency anaemia

168

2.76

9.26

1.2

1.1

80.04

86.57

u/l

0.24

125

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

4.08

9.25

1.3

1.1

113.68

92.05

u/l

0.45

Genitourinary diseases

178

523

1.71

9.22

1.1

91.96

85.47

u/l

0.27

143

416

Type 2 diabetes, definitions combined

321

1304

1.47

9.20

1.1

91.73

80.77

u/l

1.27

272

1038

Neurological diseases

291

971

1.51

9.16

1.2

1.1

89.68

84.14

u/l

0.34

231

770

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

426

2.04

9.16

1.1

75.52

76.45

u/l

0.05

322

Oesophageal varices

3.93

9.16

1.1

135.26

78.06

u/l

1.43

Neurotic, stress-related and somatoform disorders

298

1433

1.48

9.11

1.2

1.1

96.89

82.93

u/l

1.10

237

1153

Malignant neoplasm of prostate

123

416

1.87

9.05

1.2

1.1

76.94

103.20

u/l

1.98

337

Unspecified haematuria

142

694

1.76

9.05

1.1

87.60

86.18

u/l

0.09

111

535

Thyrotoxicosis with diffuse goitre

247

2.40

9.01

1.2

1.1

67.84

81.22

u/l

1.11

195

Other symptoms and signs involving the digestive system and abdomen

303

2.26

9.01

1.1

88.30

82.28

u/l

0.21

235

Psoriasis vulgaris

329

2.20

8.98

1.1

81.85

90.39

u/l

0.32

260

Ischemic heart diseases

280

1171

1.50

8.93

1.2

1.1

113.12

81.92

u/l

2.78

219

936

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

230

2.45

8.92

1.1

91.73

90.33

u/l

0.04

173

Arthropathies

297

1013

1.49

8.91

1.2

1.1

82.19

84.27

u/l

0.15

244

803

Asthma, unspecified (mode), excluding more controls

167

783

1.68

8.90

1.1

79.15

81.18

u/l

0.15

129

608

Other diseases of anus and rectum

107

567

1.89

8.87

1.1

83.19

88.83

u/l

0.33

434

Thyrotoxicosis

100

519

1.93

8.86

1.1

67.58

83.32

u/l

2.27

408

Direct fill therapy

213

2.50

8.84

1.2

1.1

98.55

86.38

u/l

0.37

170

Other general symptoms and signs

4.06

8.83

1.1

71.21

72.52

u/l

0.04

Peripheral arterial reconstruction

268

2.32

8.82

1.2

1.1

120.05

88.35

u/l

1.04

199

Diseases of external ear

116

633

1.84

8.81

1.1

91.16

84.83

u/l

0.22

494

Elevated blood glucose level

113

3.12

8.79

1.1

122.53

76.22

u/l

1.73

Gingivitis and periodontal diseases

309

1082

1.48

8.78

1.1

80.38

87.85

u/l

0.82

234

870

Atherosclerosis, excluding cerebral and coronary sclerosis

146

675

1.73

8.78

1.2

1.1

132.01

85.98

u/l

2.41

117

503

Mood disorders

346

1591

1.43

8.75

1.1

85.84

85.43

u/l

0.03

259

1287

Type 2 diabetes, strict (exclude DM1)

321

1319

1.46

8.73

1.1

91.90

82.27

u/l

1.03

271

1051

Mood [affective] disorders

345

1589

1.43

8.72

1.1

85.94

85.45

u/l

0.03

258

1287

Anxiety disorders

299

1448

1.47

8.71

1.2

1.1

96.89

83.08

u/l

1.09

237

1167

Psychiatric diseases

384

1360

1.42

8.71

1.2

1.1

93.17

82.50

u/l

0.99

303

1096

Concussion

155

794

1.69

8.69

1.1

86.31

82.76

u/l

0.13

118

644

Other specified/unspecified arthritis

513

1.92

8.48

1.1

94.53

87.79

u/l

0.19

414

Graves disease, strict definition

165

2.68

8.46

1.2

1.1

65.81

78.84

u/l

1.11

134

Spondylopathies (FG)

200

2.51

8.44

1.1

78.89

90.33

u/l

0.31

153

Other joint disorders

282

1011

1.49

8.40

1.1

80.74

84.17

u/l

0.29

220

801

Missing teeth due to accident, extraction or parodontitis

201

2.50

8.37

1.1

96.93

92.82

u/l

0.10

160

Hypertensive heart and/or renal disease

356

1.99

8.36

1.2

1.1

88.37

82.00

u/l

0.26

276

Weight loss

155

2.73

8.34

1.0

1.1

80.47

80.93

u/l

0.01

113

Heart failure and coronary heart disease

113

457

1.85

8.33

1.1

133.12

84.26

u/l

1.92

352

Disorders of continuity of bone

133

2.88

8.31

1.2

1.1

117.28

80.29

u/l

0.51

106

Candidiasis

226

2.40

8.29

1.2

1.1

99.97

80.08

u/l

0.85

171

Supplementary factors related to causes of morbidity and mortality classified elsewhere

103

553

1.87

8.26

1.2

1.1

93.06

83.49

u/l

0.25

442

Alcoholic liver disease

145

2.78

8.21

1.1

112.21

101.11

u/l

0.18

114

Pain (limb, back, neck, head abdominally)

250

826

1.52

8.12

1.1

94.14

85.84

u/l

0.47

194

652

STROKE

201

891

1.57

8.05

1.1

107.00

80.05

u/l

1.81

148

723

Type 1 diabetes, definitions combined

103

3.11

8.04

1.2

1.1

76.39

74.16

u/l

0.08

Bacterial intestinal infections, IBD co-morbidities

319

2.14

7.99

1.1

104.33

85.67

u/l

0.50

246

Use of hypnotics and sedatives

365

1512

1.40

7.98

1.1

86.16

85.71

u/l

0.03

280

1214

Asthma

249

887

1.51

7.96

1.1

79.41

84.38

u/l

0.45

193

678

Type 1 diabetes, strict (exclude DM2)

104

3.08

7.92

1.2

1.1

76.39

74.40

u/l

0.07

Functional dyspepsia

512

1.88

7.89

1.1

82.22

84.14

u/l

0.10

400

Soft tissue disorders

336

1230

1.42

7.89

1.2

1.1

85.73

85.69

u/l

0.00

269

974

Asthma (mode)

246

898

1.51

7.88

1.1

79.60

84.53

u/l

0.45

191

688

Headache

195

1047

1.56

7.87

1.1

85.77

82.79

u/l

0.17

148

836

Acute bronchitis

134

773

1.70

7.87

1.2

1.1

91.55

86.87

u/l

0.24

104

612

Abnormal spermatozoa

166

2.61

7.84

1.2

1.1

73.29

111.06

u/l

2.31

129

Asthma, unspecified (mode)

169

832

1.61

7.81

1.1

80.55

84.24

u/l

0.28

130

641

Haemorrhage from respiratory passages

114

595

1.78

7.80

1.1

92.73

89.06

u/l

0.20

456

Myocardial infarction

172

768

1.61

7.77

1.1

125.86

82.94

u/l

2.28

134

597

Sicca syndrome [Sjögren]

151

2.67

7.63

1.1

96.23

78.61

u/l

0.88

113

Conduction disorders

438

1.87

7.62

1.1

97.72

86.38

u/l

0.70

332

Parodontitis or operation codes

305

1585

1.42

7.62

1.2

1.1

81.71

87.59

u/l

0.67

235

1269

In situ neoplasms

109

583

1.79

7.58

1.1

80.26

82.08

u/l

0.11

447

Arthropathic psoriasis

193

2.45

7.56

1.1

79.37

85.53

u/l

0.16

153

Depression or dysthymia

244

916

1.49

7.53

1.1

87.89

85.03

u/l

0.17

188

738

Abnormal findings on diagnostic imaging of other body structures

224

2.34

7.53

1.1

89.68

78.64

u/l

0.25

165

Acute pancreatitis (for exclusion)

354

2.04

7.51

1.1

111.82

94.22

u/l

0.33

274

Dental caries 3

279

980

1.46

7.50

1.1

82.56

86.08

u/l

0.22

220

785

Parodontitis

304

1585

1.42

7.50

1.2

1.1

81.71

87.55

u/l

0.66

234

1269

Chronic periodontitis, including avohilmo

303

1585

1.42

7.50

1.2

1.1

81.63

87.57

u/l

0.68

233

1269

Acute upper respiratory infections

352

1592

1.39

7.49

1.2

1.1

81.49

86.61

u/l

0.67

283

1260

Leisure time condition

282

2.17

7.46

1.1

69.09

84.80

u/l

1.48

223

Congenital malformations, deformations and chromosomal abnormalities

183

1130

1.55

7.46

1.2

1.1

90.07

84.34

u/l

0.27

148

914

Coronary atherosclerosis

232

1002

1.50

7.43

1.1

110.19

83.19

u/l

2.21

187

798

Carbimazole or st.post thyroidectomy, condition for graves disease

404

1.96

7.39

1.1

67.67

79.72

u/l

1.43

316

Idiopathic gout

120

2.85

7.37

1.0

1.1

104.93

95.47

u/l

0.23

Alcohol use disorder, Swedish definition

172

1019

1.57

7.31

1.1

108.20

85.29

u/l

1.04

141

803

Sensorineural hearing loss

254

1223

1.46

7.24

1.1

91.12

88.42

u/l

0.15

212

945

Malignant neoplasm of breast, HER-negative

400

1.96

7.23

1.1

75.53

80.67

u/l

0.32

305

Parodontitis and operation codes

288

1582

1.42

7.22

1.1

80.46

87.61

u/l

0.85

220

1268

Other CVD

319

2.08

7.22

1.2

1.1

108.43

88.56

u/l

0.39

247

Other diseases of the respiratory system

353

2.02

7.20

1.2

1.1

103.18

88.88

u/l

0.53

266

Other respiratory disorders and diseases

353

2.02

7.20

1.2

1.1

103.18

88.88

u/l

0.53

266

Viral pneumonia

168

2.51

7.15

1.2

1.1

99.35

83.79

u/l

0.41

127

Vitamin deficiency

3.57

7.15

1.2

1.1

74.65

80.80

u/l

0.15

Vitamin deficiency, wide

3.57

7.15

1.2

1.1

74.65

80.80

u/l

0.15

Ischaemic heart disease, wide definition

268

1165

1.44

7.13

1.2

1.1

113.50

82.19

u/l

2.76

217

919

Fentanyl

151

2.60

7.09

1.1

105.30

88.17

u/l

0.40

117

Fracture of lumbar spine and pelvis

382

1.97

7.09

1.1

92.66

90.36

u/l

0.08

292

Internal derangement of knee

128

766

1.67

7.08

1.2

1.1

74.75

88.28

u/l

1.81

106

607

Other and unspecified local infections of skin and subcutaneous tissue

134

2.70

7.08

1.1

132.55

83.02

u/l

0.62

Examination and observation for other reasons

174

672

1.58

7.03

1.2

1.1

100.17

83.03

u/l

0.99

147

541

Pain, not elsewhere classified

468

1.86

7.01

1.1

89.16

81.78

u/l

0.39

379

Other local infections of skin and subcutaneous tissue

152

2.58

7.01

1.1

131.47

80.18

u/l

0.68

111

Gonarthrosis

226

871

1.49

7.01

1.1

88.75

88.07

u/l

0.03

180

688

Injuries to the head

353

1683

1.37

6.99

1.1

96.65

83.16

u/l

1.21

269

1349

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

230

2.24

6.96

1.2

1.1

81.36

91.23

u/l

0.29

184

Myocardial infarction, without ST-elevation

130

724

1.66

6.96

1.2

1.1

129.63

88.42

u/l

1.71

100

556

187

1101

1.52

6.95

1.1

108.62

84.01

u/l

1.30

154

870

Other or unspecified ileus, impaction or obstruction

304

2.08

6.93

1.3

1.1

91.98

90.88

u/l

0.02

220

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

278

2.13

6.92

1.2

1.1

153.18

84.89

u/l

1.75

212

Chronic gastritis

529

1.80

6.87

1.1

80.38

90.35

u/l

0.90

396

Open wound of ankle and foot

142

2.62

6.86

1.2

1.1

153.69

84.63

u/l

0.80

112

Cystitis

288

1249

1.41

6.81

1.1

79.83

86.58

u/l

0.93

214

1012

Diseases of pulp and periapical tissues, including avohilmo

350

1326

1.37

6.81

1.2

1.1

87.63

86.52

u/l

0.07

281

1064

Other follicular disorders

2.98

6.80

1.1

85.15

91.08

u/l

0.20

Pyogenic arthritis

2.98

6.80

1.1

1.0

105.33

93.86

u/l

0.22

Disorders of sclera, cornea, iris and ciliary body

176

1152

1.53

6.79

1.1

78.75

88.25

u/l

1.08

142

925

Polycystic ovarian syndrome, consortium definition

244

1013

1.46

6.79

1.2

1.1

73.65

81.18

u/l

1.35

196

813

Conductive and sensorineural hearing loss

264

1283

1.43

6.79

1.1

88.49

87.60

u/l

0.05

219

996

Other gastritis (incl. Duodenitis)

403

1.92

6.77

1.1

107.83

89.26

u/l

0.49

303

Faecal incontinence

155

2.53

6.76

1.2

62.59

81.34

u/l

1.68

117

Unspecified jaundice

3.65

6.75

1.0

1.1

173.93

83.81

u/l

1.18

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

255

2.17

6.72

1.2

1.1

76.98

83.35

u/l

0.34

216

Disorders of synovium and tendon

178

1052

1.53

6.69

1.1

100.98

85.99

u/l

0.70

139

834

Asthma (only as main-diagnosis), excluding more controls

209

833

1.50

6.68

1.1

77.64

81.64

u/l

0.35

162

642

Type of accident

505

1.81

6.67

1.2

1.1

91.15

83.49

u/l

0.17

400

Other disorders of lacrimal gland

122

736

1.66

6.65

1.1

82.97

86.11

u/l

0.17

583

Low back pain

239

1278

1.44

6.63

1.1

74.09

87.23

u/l

2.78

190

1018

Open wound of head

161

1023

1.55

6.63

1.1

95.93

85.06

u/l

0.92

131

809

Other abnormal findings of blood chemistry

3.59

6.60

1.1

1.2

70.00

79.78

u/l

0.25

All influenza (not pneumonia)

212

2.27

6.60

1.2

1.1

98.63

89.23

u/l

0.25

163

Other diseases of blood and blood-forming organs

100

2.92

6.58

1.2

1.1

129.21

80.67

u/l

1.41

Benign neoplasm of colon, rectum, anus and anal canal

205

1256

1.48

6.56

1.1

93.32

88.11

u/l

0.38

173

976

Injuries to the elbow and forearm

225

1408

1.45

6.50

1.2

1.1

78.13

87.03

u/l

1.02

166

1137

Other abnormal uterine and vaginal bleeding

358

1.82

6.43

1.2

1.1

84.43

86.82

u/l

0.11

276

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

147

2.53

6.43

1.1

104.84

86.96

u/l

0.55

110

Seronegative rheumatoid arthritis

202

2.29

6.43

1.1

65.83

85.80

u/l

1.55

145

Other acute lower respiratory infections

161

998

1.54

6.42

1.1

96.61

86.59

u/l

0.58

126

795

Other CVD (FINNGEN)

132

2.46

6.37

1.2

1.1

111.24

72.84

u/l

0.54

111

Benign neoplasm of other and ill-defined parts of digestive system

342

1.97

6.37

1.1

89.20

90.28

u/l

0.05

261

Dental pulpitis 1

347

1329

1.36

6.35

1.2

1.1

87.87

86.46

u/l

0.09

279

1066

Dental pulpitis 4

347

1329

1.36

6.35

1.2

1.1

87.87

86.46

u/l

0.09

279

1066

Pacemaker

106

606

1.70

6.34

1.1

98.53

95.19

u/l

0.16

461

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

455

1.83

6.34

1.2

1.1

77.34

82.45

u/l

0.37

380

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

114

685

1.67

6.33

1.1

86.65

84.75

u/l

0.05

550

Intestinal malabsorption

3.27

6.28

1.3

1.1

104.77

90.70

u/l

0.32

Other respiratory diseases principally affecting the interstitium

296

2.04

6.27

1.2

1.1

90.65

91.69

u/l

0.03

221

Ankylosing spondylitis, ICD10

138

2.55

6.19

1.1

64.92

83.31

u/l

1.39

107

Other problems related to primary support group, including family circumstances

152

2.45

6.15

1.2

1.1

81.58

75.30

u/l

0.31

128

Substance abuse, excluding more controls

170

986

1.51

6.12

1.1

106.71

81.96

u/l

1.46

142

798

Other diseases of intestine

188

2.30

6.09

1.1

86.72

87.30

u/l

0.02

134

Diseases of the musculoskeletal system and connective tissue

158

507

1.57

6.02

1.2

1.1

76.18

84.34

u/l

0.76

131

399

Other arrhythmias

204

1074

1.46

6.01

1.1

82.18

81.08

u/l

0.09

166

857

Myocardial infarction, strict

153

722

1.55

6.00

1.2

1.1

125.49

84.57

u/l

1.95

122

559

Dental operations

212

743

1.47

6.00

1.1

90.45

88.00

u/l

0.11

166

594

Bronchitis

339

1661

1.34

5.98

1.2

1.1

88.10

84.83

u/l

0.30

271

1317

COPD (mode)

446

1.73

5.96

1.2

1.1

96.78

88.04

u/l

0.47

322

Diverticular disease of intestine

233

1088

1.42

5.96

1.2

1.1

79.83

87.09

u/l

0.74

197

841

Coxarthrosis [arthrosis of hip](FG)

170

815

1.51

5.95

1.1

82.43

85.83

u/l

0.18

138

635

Alcohol-induced chronic pancreatitis

3.00

5.95

1.1

118.05

93.65

u/l

0.28

Polyp of the female genital tract

122

432

1.65

5.90

1.2

1.1

85.52

83.31

u/l

0.10

341

Acute upper respiratory infections of multiple and unspecified sites

230

1216

1.42

5.88

1.2

1.1

83.66

85.17

u/l

0.12

186

965

Symptoms and signs involving the nervous and musculoskeletal systems

184

1255

1.47

5.87

1.1

89.16

85.29

u/l

0.15

113

1031

Major coronary heart disease event

229

1075

1.42

5.84

1.1

117.62

81.77

u/l

2.39

168

849

Factors influencing health status and contact with health services

250

1.81

5.83

1.1

84.18

85.98

u/l

0.06

198

Other diseases of oesophagus

131

2.53

5.77

1.1

1.2

117.08

97.51

u/l

0.18

Benign neoplasm: Colon, unspecified

388

1.85

5.76

1.2

1.1

106.90

85.87

u/l

0.90

292

172

1066

1.48

5.74

1.1

104.15

85.25

u/l

0.99

143

839

Pleural effusion

252

2.07

5.74

1.1

122.20

91.84

u/l

1.35

190

therapeutic use

3.95

5.73

1.4

1.1

96.44

79.03

u/l

0.44

Mental and behavioural disorders due to psychoactive substance use

179

1151

1.47

5.72

1.1

105.93

84.47

u/l

1.27

150

910

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

200

2.21

5.71

1.1

113.93

87.29

u/l

1.05

150

Benign neoplasms

301

1237

1.36

5.70

1.2

1.1

96.83

83.88

u/l

1.04

245

978

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

124

605

1.60

5.69

1.1

97.88

83.37

u/l

0.87

105

466

Secondary and unspecified malignant neoplasm of lymph nodes

132

2.52

5.69

1.1

105.84

88.07

u/l

0.74

101

Disorders of lacrimal system

143

933

1.54

5.69

1.1

81.65

87.27

u/l

0.42

116

744

Benign neoplasm: Colon

169

1119

1.48

5.66

1.2

1.1

95.45

85.44

u/l

0.80

147

863

Injuries to the ankle and foot

206

1316

1.43

5.63

1.2

1.1

92.10

82.53

u/l

0.51

159

1067

Disorders of eyelid, lacrimal system and orbit

276

1590

1.36

5.63

1.1

82.85

86.25

u/l

0.31

217

1272

Other disorders of conjunctiva

254

2.06

5.63

1.1

68.77

85.48

u/l

1.27

191

Poisoning by medicine

358

1.88

5.61

1.2

1.1

78.06

82.60

u/l

0.24

297

Paracetamol of NSAID medication

117

2.20

5.60

1.1

87.89

76.93

u/l

0.34

Asthma (only as main-diagnosis)

211

887

1.44

5.59

1.1

78.02

84.38

u/l

0.60

164

678

Substance use, excluding alcohol

310

1.94

5.55

1.2

1.1

83.74

88.76

u/l

0.21

249

Retention of urine

500

1.68

5.53

1.1

104.26

92.77

u/l

0.31

386

Dental caries 3, only avohilmo

275

1024

1.38

5.50

1.1

86.23

85.97

u/l

0.01

217

821

Gonarthrosis,primary

300

1402

1.35

5.49

1.2

1.1

86.35

86.27

u/l

0.00

238

1110

Respiratory insufficiency

105

2.67

5.47

1.1

96.70

84.08

u/l

0.30

Degeneration of macula and posterior pole

147

799

1.52

5.45

1.2

1.1

94.79

85.91

u/l

0.68

118

610

ILD, hospital admission 2, with pulmonary infections

129

2.49

5.44

1.1

84.12

97.73

u/l

0.47

Dental caries, including avohilmo

251

922

1.39

5.44

1.1

83.96

86.54

u/l

0.14

198

744

Keratitis

110

683

1.61

5.44

1.1

82.76

90.21

u/l

0.60

545

Dental caries 1

251

922

1.39

5.43

1.1

83.96

86.54

u/l

0.14

198

744

Methotrexate

251

2.04

5.42

1.2

1.1

77.45

81.40

u/l

0.13

184

Chronic lower respiratory diseases

386

1606

1.30

5.41

1.1

86.02

85.29

u/l

0.06

305

1289

Hypopituitarism

2.82

5.40

1.2

1.1

142.89

85.55

u/l

0.47

Ankylosing spondylitis

154

2.35

5.39

1.1

64.37

95.28

u/l

1.98

125

Stroke, including SAH

200

1036

1.43

5.39

1.1

109.73

84.66

u/l

1.50

140

825

ILD, hospital admissions 3, with pneumonia sepsis

112

2.60

5.38

1.1

88.05

91.39

u/l

0.08

Abnormal weight loss

142

2.41

5.37

1.0

1.1

86.63

82.24

u/l

0.13

103

Other skin changes

314

1.92

5.37

1.2

1.1

111.84

85.56

u/l

0.89

233

Primary gonarthrosis, bilateral

174

1044

1.46

5.37

1.1

88.65

89.00

u/l

0.02

140

821

Neovascular glaucoma

3.30

5.31

1.2

1.1

102.81

77.58

u/l

0.59

Pulmonary heart disease, diseases of pulmonary circulation

101

618

1.64

5.30

1.1

99.44

89.11

u/l

0.54

476

Stroke, excluding SAH

188

970

1.44

5.30

1.1

111.12

85.51

u/l

1.44

133

766

Polyarthrosis

391

1.80

5.29

1.2

1.1

84.86

84.52

u/l

0.01

305

Spondylopathies

268

1195

1.36

5.29

1.2

1.1

86.19

88.14

u/l

0.10

212

953

Early onset COPD, excluding more controls

353

1.85

5.19

1.2

1.1

93.05

88.66

u/l

0.17

260

Colectomy operation

297

1.93

5.18

1.2

1.1

96.17

91.97

u/l

0.11

227

ILD, hospital admissions

242

2.03

5.18

1.2

1.1

94.39

92.68

u/l

0.04

179

Mixed hyperlipidaemia

3.25

5.18

1.2

1.1

87.02

98.34

u/l

0.30

Glaucoma secondary to other eye disorders

3.25

5.18

1.2

1.1

102.81

83.00

u/l

0.42

Suicide or other Intentional self-harm

441

1.75

5.18

1.2

1.1

77.53

85.02

u/l

0.54

357

Injuries to the abdomen, lower back, lumbar spine and pelvis

117

742

1.57

5.16

1.1

92.48

88.12

u/l

0.19

582

Substance abuse

170

1121

1.45

5.15

1.1

106.71

84.99

u/l

1.19

142

887

Intracranial injury

169

1126

1.45

5.15

1.1

89.99

85.27

u/l

0.18

126

888

Acute suppurative otitis media

323

1.85

5.14

1.2

1.1

95.83

74.53

u/l

0.52

265

External causes of morbidity and mortality

220

782

1.41

5.13

1.2

1.1

85.49

81.26

u/l

0.27

180

608

ILD, hospital admissions 1, main diag only

216

2.09

5.13

1.2

1.1

92.76

94.23

u/l

0.03

160

Lower back pain or/and sciatica

321

1694

1.32

5.12

1.1

76.73

87.48

u/l

1.75

255

1349

Non-selective monoamine reuptake inhibitors

134

857

1.52

5.11

1.1

78.03

92.58

u/l

1.22

103

685

Exclusions for E4_PCOS_CONSORTIUM

235

1067

1.38

5.09

1.2

1.1

83.84

81.96

u/l

0.10

191

857

Osteonecrosis

2.86

5.09

1.1

91.94

82.98

u/l

0.22

Orthopaedic devices associated with adverse incidents

4.52

5.06

1.4

1.1

90.08

92.95

u/l

0.04

Other interstitial pulmonary diseases

245

2.01

5.02

1.2

1.1

94.39

93.02

u/l

0.03

181

Contact with and exposure to communicable diseases

488

1.70

5.02

1.2

1.1

85.40

78.97

u/l

0.32

401

Infections with a predominantly sexual mode of transmission

528

1.67

5.00

1.2

1.1

105.80

76.83

u/l

1.11

433

Disorders of skin appendages

144

969

1.49

4.99

1.1

87.38

86.16

u/l

0.05

125

777

Interstitial lung disease

246

2.00

4.97

1.2

1.1

94.39

92.62

u/l

0.04

182

Interstitial lung disease endpoints

246

2.00

4.97

1.2

1.1

94.39

92.62

u/l

0.04

182

Mixed connective tissue disease

111

2.54

4.96

1.1

93.73

77.45

u/l

0.60

severe traumatic brain injury, does not include concussion

359

1.82

4.95

1.1

95.51

95.67

u/l

0.00

280

Other external causes of accidental injury

274

1017

1.35

4.94

1.1

92.45

81.34

u/l

0.80

215

803

Coeliac disease

193

2.13

4.93

1.2

1.1

112.97

78.47

u/l

0.50

150

Secondary uncertain malignant neoplasm

213

2.07

4.92

1.2

1.1

134.10

85.77

u/l

1.50

161

Other and unspecified nail disorders

4.12

4.91

1.0

1.2

83.75

94.58

u/l

—

Hypoparathyroidism

3.36

4.89

1.2

1.1

258.25

75.10

u/l

0.88

Cerebrovascular diseases

234

1227

1.37

4.89

1.1

106.20

85.72

u/l

1.35

170

979

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

130

2.40

4.88

1.2

1.1

116.70

74.99

u/l

0.43

Diseases of salivary glands

347

1.82

4.85

1.1

126.21

89.77

u/l

0.67

278

Dental pulpitis 2, only avohilmo

228

843

1.39

4.85

1.1

86.33

86.62

u/l

0.01

179

683

Anxiety (asthma-related co-morbidities)

174

959

1.43

4.82

1.2

98.76

78.56

u/l

1.13

137

787

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

309

1535

1.31

4.81

1.2

1.1

90.26

85.78

u/l

0.41

240

1236

Disorders of conjunctiva

249

1551

1.35

4.80

1.2

1.1

80.00

86.18

u/l

0.63

210

1235

Tubulo-interstitial nephritis, not specified as acute or chronic

2.68

4.74

1.3

1.1

72.73

91.38

u/l

0.58

Otitis externa

387

1.76

4.71

1.2

1.1

95.08

83.90

u/l

0.24

307

Hypotension

251

1.96

4.71

1.2

1.1

118.50

90.73

u/l

0.36

189

Gonarthrosis, primary, with knee surgery

187

1088

1.41

4.71

1.1

85.84

87.93

u/l

0.15

151

853

Dental pulpitis 2

220

814

1.39

4.69

1.1

86.91

86.72

u/l

0.01

172

655

Arthrosis

228

914

1.37

4.67

1.1

86.30

87.20

u/l

0.04

184

725

Temporomandibular joint disorders

287

1.89

4.66

1.1

94.24

82.51

u/l

0.37

238

Persons with potential health hazards related to communicable diseases

103

650

1.57

4.65

1.2

1.1

85.94

81.38

u/l

0.25

528

Superficial injury of hip and thigh

225

2.01

4.63

1.3

1.1

106.44

80.79

u/l

0.81

175

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

3.52

4.62

1.1

163.86

78.67

u/l

—

Poisoning by drugs, medicaments and biological substances

397

1.74

4.61

1.2

1.1

78.56

83.26

u/l

0.26

326

Acute sinusitis

154

995

1.44

4.60

1.1

78.63

85.99

u/l

0.66

124

800

Traumatic subdural haemorrhage

189

2.09

4.57

1.1

109.75

85.55

u/l

0.53

147

Ischaemic Stroke, excluding all haemorrhages

173

923

1.42

4.55

1.1

110.37

85.44

u/l

1.36

124

726

Infective dermatitis

173

2.15

4.55

1.1

127.42

89.45

u/l

0.61

135

Personality disorders, excluding more controls

399

1.73

4.54

1.2

1.1

95.10

82.94

u/l

0.23

337

Other diseases of lip and oral mucosa

276

1.89

4.52

1.2

1.1

77.79

89.05

u/l

0.78

219

Urticaria and erythema

113

740

1.53

4.52

1.2

1.1

91.40

82.91

u/l

0.56

595

Fracture of forearm

174

1160

1.41

4.50

1.1

79.55

87.54

u/l

0.68

129

932

Other noninflammatory disorders of vulva and perineum

142

2.26

4.47

1.3

1.2

94.52

75.96

u/l

1.00

112

Other and unspecified psoriasis

105

2.49

4.46

1.2

1.1

73.81

78.70

u/l

0.17

Symptoms and signs involving the skin and subcutaneous tissue

213

1565

1.36

4.45

1.2

1.1

88.27

84.83

u/l

0.24

172

1244

Polymyalgia rheumatica

209

2.02

4.40

1.1

93.01

80.96

u/l

0.22

151

Viral and other specified intestinal infections

259

1.89

4.35

1.2

1.1

122.10

76.05

u/l

0.84

205

Atopic dermatitis, strict definition with reimbursement

480

1.64

4.33

1.2

1.1

71.90

80.26

u/l

0.69

387

Injuries to the thorax

129

877

1.47

4.32

1.2

1.1

92.50

88.57

u/l

0.12

106

693

Major coronary heart disease event excluding revascularizations

198

995

1.38

4.31

1.1

119.27

82.33

u/l

2.24

156

781

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

151

716

1.44

4.30

1.2

1.1

87.44

84.37

u/l

0.17

122

554

Biguanides

303

1444

1.29

4.29

1.1

88.87

86.22

u/l

0.19

247

1146

Viral warts

145

2.22

4.27

1.3

1.1

89.85

83.82

u/l

0.21

113

Hernia of abdominal wall

134

921

1.46

4.26

1.2

1.1

95.74

88.67

u/l

0.26

117

715

Moderate visual impairment, binocular

3.90

4.26

1.4

1.1

76.08

88.88

u/l

0.24

Injuries to the knee and lower leg

366

1658

1.26

4.26

1.1

91.07

83.93

u/l

0.70

310

1300

Postprocedural endocrine and metabolic disorders, not elsewhere classified

212

1.99

4.25

1.1

119.92

77.23

u/l

0.58

173

Other metabolic disorders

233

1.94

4.24

1.1

113.25

77.17

u/l

0.53

184

Suppurative and unspecified otitis media

502

1.59

4.23

1.2

1.1

106.70

83.14

u/l

0.65

397

Postprocedural musculoskeletal disorders, not elsewhere classified

114

2.38

4.23

1.2

1.1

85.62

79.88

u/l

0.18

All anxiety disorders

175

1013

1.39

4.21

1.2

1.1

98.24

79.59

u/l

1.01

138

816

Other diseases of upper respiratory tract

356

1465

1.27

4.18

1.1

78.99

87.97

u/l

1.08

288

1155

Trigger finger

284

1.84

4.17

1.3

1.1

100.78

87.07

u/l

0.23

225

Hypertensive Heart Disease

332

1.70

4.17

1.2

1.1

89.98

82.57

u/l

0.26

256

Dental operations, only avohilmo

219

828

1.36

4.16

1.1

90.30

87.04

u/l

0.15

170

669

Pulmonary embolism

564

1.58

4.15

1.2

1.1

99.38

89.54

u/l

0.46

430

Coxarthrosis

157

750

1.42

4.15

1.1

84.33

86.72

u/l

0.11

127

585

Other other unspecified disorders of the circulatory system

3.01

4.13

1.1

1.2

89.47

82.20

u/l

0.19

Myalgia

426

1.67

4.12

1.1

93.60

83.14

u/l

0.50

346

Other (seronegative) rheumatoid arthritis, wide

381

1.71

4.12

1.1

75.90

87.42

u/l

0.83

289

Rheumatism, unspecified

300

1.81

4.11

1.1

68.40

76.94

u/l

0.65

234

L02BB Anti-androgens

122

2.31

4.10

1.3

1.1

75.15

110.46

u/l

1.05

Traumatic subarachnoid haemorrhage

3.54

4.05

1.2

1.0

132.26

101.31

u/l

—

Follow-up examination after treatment for malignant neoplasms

175

2.07

4.05

1.1

78.03

83.21

u/l

0.23

136

Dental pulpitis 4, only avohilmo

340

1401

1.27

4.01

1.1

87.37

86.58

u/l

0.05

271

1129

Pulmonary heart disease

569

1.57

4.01

1.2

1.1

99.38

89.72

u/l

0.45

435

Sarcoidosis

238

1.90

4.00

1.1

92.27

82.37

u/l

0.43

187

Dorsalgia

308

1302

1.28

4.00

1.1

79.75

86.74

u/l

0.74

246

1035

Selective serotonin reuptake inhibitors

312

1284

1.28

3.98

1.1

79.66

87.74

u/l

0.95

246

1024

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

523

1.59

3.98

1.2

1.1

77.34

82.48

u/l

0.38

429

Fall on same level involving ice and snow

169

1228

1.38

3.96

1.1

95.37

87.07

u/l

0.35

120

997

Dental caries 1, only avohilmo

249

966

1.32

3.96

1.1

85.23

86.58

u/l

0.07

197

780

Presbycusis

203

1.97

3.95

1.1

78.41

91.63

u/l

0.67

140

Abnormalities of heart beat

103

677

1.51

3.94

1.1

86.13

86.08

u/l

0.00

533

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

3.67

3.93

1.1

180.83

92.75

u/l

—

Nail disorders

131

2.22

3.92

1.1

135.39

80.51

u/l

0.65

103

Fracture of rib(s), sternum and thoracic spine

534

1.58

3.89

1.1

101.12

89.37

u/l

0.26

426

Superficial injury of ankle and foot

158

2.10

3.87

1.2

1.1

87.31

77.88

u/l

0.26

127

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

444

1.63

3.87

1.1

83.56

78.00

u/l

0.38

357

Colorectal cancer, excluding all cancers (controls excluding all cancers)

449

1.62

3.86

1.1

85.19

87.67

u/l

0.11

346

Bacterial, viral and other infectious agents

107

2.35

3.82

1.3

1.1

129.34

82.18

u/l

1.04

Seborrhoeic dermatitis

139

2.17

3.82

1.3

1.1

110.59

95.67

u/l

0.24

103

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

146

2.13

3.80

1.1

130.96

88.07

u/l

0.51

110

Speech disturbances, not elsewhere classified

133

2.19

3.79

1.1

94.78

86.95

u/l

0.21

Diagnoses used for exclusion with ILD

483

1.60

3.79

1.1

92.35

89.37

u/l

0.10

381

Superficial injury of lower leg

437

1.63

3.77

1.1

103.39

84.72

u/l

0.85

338

Duodenal ulcer

160

2.07

3.75

1.1

89.04

102.83

u/l

0.46

116

181

1.99

3.72

1.3

1.1

135.83

78.42

u/l

0.85

153

Autoimmune hyperthyroidism

2.58

3.71

1.2

1.1

62.36

80.68

u/l

1.11

Seropositive rheumatoid arthritis, strict definition

288

1.78

3.71

1.2

1.1

71.90

79.47

u/l

0.61

224

Accidents

263

1017

1.30

3.70

1.1

92.69

81.34

u/l

0.79

206

803

Acute and subacute iridocyclitis

348

1.70

3.69

1.2

1.1

70.26

89.68

u/l

1.13

274

Calcific aortic valvular stenosis, including rheumatic fever

529

1.56

3.69

1.1

111.99

95.91

u/l

0.46

400

Other sleep disorders

168

2.03

3.69

1.1

66.56

93.31

u/l

1.74

135

Other extrapyramidal and movement disorders in other diseases

425

1.63

3.67

1.1

71.04

89.25

u/l

2.06

330

Other specified/unspecified systemic involvement of connective tissue

2.39

3.65

1.1

1.2

95.69

77.65

u/l

0.66

Type 1 diabetes, strict definition, subgroup 1

2.69

3.63

1.1

1.0

75.62

75.25

u/l

0.01

Fracture of foot, except ankle

434

1.62

3.63

1.2

1.1

82.74

78.61

u/l

0.22

343

Presence of other devices

403

1.64

3.62

1.1

79.33

91.50

u/l

0.91

301

Other neurological diseases

217

1333

1.31

3.59

1.1

94.48

86.26

u/l

0.42

162

1061

Myocardial infarction, unclassifiable

332

1.67

3.58

1.1

139.87

90.60

u/l

1.06

251

Benign paroxysmal vertigo

602

1.52

3.57

1.1

82.68

87.95

u/l

0.24

466

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

170

2.00

3.56

1.1

75.13

89.02

u/l

0.58

130

Operations 2 for CAVS

527

1.54

3.55

1.1

111.99

95.92

u/l

0.46

398

Calcific aortic valvular stenosis, diagnosis (helper)

527

1.54

3.55

1.1

111.99

95.92

u/l

0.46

398

Dislocation, sprain and strain of joint and ligaments of hip

3.07

3.53

1.2

1.1

122.00

90.43

u/l

0.25

Coronary revascularization (ANGIO or CABG)

138

685

1.41

3.53

1.2

1.1

111.14

84.26

u/l

0.99

527

Dermatophytosis

213

1.88

3.52

1.1

89.31

89.16

u/l

0.00

165

Calcific aortic valvular stenosis

528

1.54

3.52

1.1

111.99

95.86

u/l

0.47

399

Calcific aortic valvular stenosis, operated

528

1.54

3.52

1.1

111.99

95.86

u/l

0.47

399

In situ neoplasms

109

751

1.45

3.51

1.1

80.26

84.39

u/l

0.29

580

Adjustment and management of implanted device

286

1.75

3.50

1.0

1.1

97.58

90.17

u/l

0.32

213

Dysphagia

423

1.61

3.49

1.1

87.01

87.32

u/l

0.01

331

Degenerative macular diseases

214

1.88

3.48

1.2

1.1

85.26

86.60

u/l

0.04

154

Unspecific neurodegenerative disorder

603

0.59

3.48

1.0

1.1

93.78

91.17

u/l

0.08

445

Pain associated with micturition

186

1.94

3.47

1.3

1.1

67.85

82.72

u/l

0.96

142

Atopic dermatitis

149

924

1.38

3.47

1.2

1.1

72.44

83.42

u/l

1.57

124

746

Dental pulpitis 1, only avohilmo

336

1410

1.25

3.46

1.1

87.23

86.44

u/l

0.05

268

1137

Other hearing loss

502

1.55

3.44

1.2

1.1

104.20

94.14

u/l

0.23

373

Open wound of wrist and hand

113

780

1.44

3.42

1.2

1.1

89.97

90.25

u/l

0.01

626

Open wound of forearm

126

2.15

3.41

1.2

1.1

82.74

85.67

u/l

0.09

Other and unspecified urticaria

342

1.67

3.38

1.2

1.1

97.22

76.65

u/l

1.09

269

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

120

2.18

3.38

1.2

1.1

69.61

70.78

u/l

0.04

Malignant melanoma, excluding all cancers (controls excluding all cancers)

282

1.74

3.38

1.2

1.1

86.48

83.58

u/l

0.08

211

Inflammatory diseases of female pelvic organs

190

1084

1.32

3.35

1.1

75.96

80.09

u/l

0.50

157

866

Symptoms and signs involving cognition, perception, emotional state and behaviour

293

1641

1.25

3.35

1.1

93.41

84.44

u/l

0.60

225

1317

Iridocyclitis

420

1.60

3.35

1.1

71.21

87.76

u/l

1.07

325

Leiomyoma of uterus

135

541

1.41

3.35

1.1

78.39

77.50

u/l

0.05

114

416

Cerebral palsy and other paralytic syndromes

175

1.95

3.32

1.2

1.1

105.31

83.09

u/l

0.52

137

Sequelae of cerebrovascular disease

100

600

1.47

3.31

1.1

104.64

90.76

u/l

0.56

473

Pleural plaque

148

2.04

3.30

1.1

127.60

98.05

u/l

0.49

111

Malignant neoplasm of endocrine gland

128

2.12

3.29

1.2

1.1

121.62

81.88

u/l

0.36

Amenorrhoea

2.48

3.29

1.2

62.90

73.25

u/l

0.43

Somatoform disorder

292

1.72

3.28

1.1

82.12

76.78

u/l

0.17

233

Benign neoplasm of other and unspecified endocrine glands

197

1.88

3.28

1.2

1.1

99.63

81.21

u/l

0.39

149

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

307

1.70

3.28

1.1

87.69

89.18

u/l

0.05

231

Menorrhagia

117

450

1.44

3.28

1.2

1.1

73.39

82.49

u/l

1.04

102

354

Open wound of lower leg

219

1.83

3.26

1.1

143.97

92.06

u/l

0.76

169

486

1.52

3.25

1.2

1.1

99.32

90.59

u/l

0.36

360

Other/unspecified rheumatoid arthritis

234

1.80

3.24

1.0

1.1

78.84

84.16

u/l

0.22

176

Viral pneumonia (unknown virus, not influenza)

2.34

3.24

1.2

1.1

82.77

81.53

u/l

0.03

Dentofacial anomalies [including malocclusion]

505

1.53

3.24

1.2

1.1

91.01

85.56

u/l

0.22

415

Injuries to the wrist and hand

289

1680

1.25

3.23

1.1

86.16

84.85

u/l

0.07

231

1338

L01XX Other antineoplastic agents

2.39

3.23

1.1

141.67

83.35

u/l

1.18

Venous thromboembolism

160

1160

1.34

3.22

1.2

1.1

90.51

88.23

u/l

0.13

132

912

Other viral diseases, not elsewhere classified

279

1.72

3.18

1.1

79.42

87.78

u/l

0.37

225

Diseases of inner ear

163

1198

1.33

3.18

1.1

82.67

88.26

u/l

0.37

132

947

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

127

627

1.40

3.18

1.2

1.1

82.66

83.29

u/l

0.03

103

483

Primary coxarthrosis, bilateral

586

1.49

3.18

1.1

81.12

89.34

u/l

0.31

446

Shoulder lesions

234

1120

1.28

3.17

1.2

1.1

86.66

87.48

u/l

0.04

192

887

Dental pulpitis 3, only avohilmo

2.33

3.17

1.2

1.1

67.50

61.70

u/l

0.27

Mental and behavioural disorders due to alcohol

137

976

1.37

3.15

1.1

110.69

84.96

u/l

1.15

114

773

Car occupant injured in other and unspecified transport accidents

296

1.69

3.14

1.1

88.89

83.64

u/l

0.15

240

Attention to artificial openings

2.97

3.14

1.0

1.1

222.20

83.77

u/l

—

Fibromyalgia

158

1.97

3.14

1.3

1.1

70.33

76.13

u/l

0.27

130

Disorder of lipoprotein metabolism, unspecified

222

1.81

3.14

1.1

92.45

94.80

u/l

0.06

168

Benign neoplasm: Rectum, anus and anal canal

319

1.67

3.13

1.2

1.1

78.62

84.19

u/l

0.30

245

Parodontitis or/and operation codes

206

943

1.30

3.13

1.1

79.46

86.88

u/l

0.73

154

758

Type 1 diabetes, strict definition

2.41

3.11

1.1

75.63

74.58

u/l

0.02

Excessive attrition of teeth

118

451

1.42

3.10

1.1

79.19

88.34

u/l

0.64

362

Disorders of vestibular function (Vertigo)

140

1025

1.36

3.10

1.1

85.41

89.14

u/l

0.19

113

812

Bronchiectasis

125

2.09

3.08

1.2

1.1

79.62

79.81

u/l

0.00

Benign neoplasm: Sigmoid colon

291

1.69

3.05

1.3

1.1

89.15

83.65

u/l

0.20

222

Anterior Iridocyclitis

376

1.60

3.04

1.1

72.16

89.19

u/l

0.95

294

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

479

1.53

3.03

1.1

80.16

90.08

u/l

0.63

384

Other disorders of cornea

154

1.96

2.99

1.1

69.14

78.72

u/l

0.58

116

Benign neoplasm: Colon, unspecified

473

1.53

2.98

1.2

1.1

106.90

88.91

u/l

0.75

363

Alcohol abuse, main dg, excluding more controls

197

1.83

2.97

1.1

99.67

92.24

u/l

0.15

160

Alzheimer disease

420

0.54

2.96

1.1

115.86

91.11

u/l

0.58

306

Herpesviral [herpes simplex] infections

176

1.88

2.94

1.1

107.08

79.13

u/l

0.71

138

Specific personality disorders

395

1.57

2.94

1.2

1.1

96.02

81.73

u/l

0.24

329

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

170

1.89

2.89

1.1

128.56

88.13

u/l

0.50

127

Fracture of lower leg, including ankle

161

1221

1.31

2.89

1.1

99.49

86.78

u/l

0.62

132

964

Diseases of spleen

4.14

2.89

1.1

97.89

91.06

u/l

—

Female genital prolapse

102

411

1.44

2.88

1.1

70.57

84.29

u/l

1.32

321

Postmenopausal bleeding

101

386

1.44

2.88

1.2

1.1

75.57

85.17

u/l

0.89

301

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

304

1.65

2.87

1.1

82.23

87.89

u/l

0.21

229

Ventral hernia

478

1.51

2.86

1.2

1.1

91.87

88.70

u/l

0.09

365

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

126

633

1.37

2.84

1.2

1.1

83.89

83.58

u/l

0.01

102

485

DVT of lower extremities and pulmonary embolism

120

874

1.37

2.84

1.2

1.1

92.30

88.90

u/l

0.17

100

680

Artificial joint operation, meniscal resection

279

1506

1.23

2.84

1.1

79.88

88.80

u/l

1.35

222

1189

Obesity, other/unspecified

659

1.43

2.83

1.1

85.37

85.60

u/l

0.01

530

Other and unspecified disorders of vitreous body

127

934

1.35

2.80

1.1

87.47

88.38

u/l

0.04

105

736

Fissure and fistula of anal and rectal regions

432

1.53

2.80

1.1

76.06

86.73

u/l

0.86

333

Hypertrophy of breast

369

1.58

2.79

1.1

65.65

76.19

u/l

1.70

296

Phobic anxiety disorders

158

1.90

2.79

1.3

1.1

91.30

73.67

u/l

0.70

140

Coronary angioplasty

108

594

1.40

2.79

1.1

93.05

85.56

u/l

0.26

460

Chronic hepatitis NAS

3.97

2.78

1.1

129.33

101.78

u/l

—

Hyperplasia of prostate

362

1.45

2.77

1.1

75.17

101.48

u/l

2.63

286

Other congenital malformations

117

2.06

2.76

1.1

120.68

81.19

u/l

0.61

Alzheimer disease, including avohilmo

494

0.60

2.75

1.0

1.1

109.25

92.84

u/l

0.52

361

Striking against or struck by other objects

547

1.46

2.75

1.2

1.1

97.72

88.84

u/l

0.33

442

Degenerative diseases of the nervous system

495

0.59

2.74

1.1

109.17

92.88

u/l

0.46

370

Emergency coronary revascularization (for ACS)

152

827

1.32

2.74

1.1

109.94

89.61

u/l

0.75

648

Ovarian cyst

113

470

1.39

2.73

1.2

1.1

74.23

80.96

u/l

0.61

371

Hypertrophy of breast in women and men

411

1.54

2.73

1.1

67.74

78.17

u/l

1.39

329

Flat foot [pes planus] (acquired)

174

1.85

2.72

1.2

1.1

85.56

79.00

u/l

0.26

133

Pre-eclampsia

412

1.53

2.70

1.1

1.2

81.98

78.42

u/l

0.13

341

Undetermined asthma, excluding more controls

196

1.79

2.70

1.1

73.41

87.81

u/l

0.54

151

Other benign neoplasms of skin

645

1.42

2.69

1.2

1.1

86.66

82.44

u/l

0.12

501

Other and unspecified trigeminal disorders

4.25

2.68

1.4

1.1

66.38

69.00

u/l

—

Haemorrhoids and perianal venous thrombosis

575

1.44

2.68

1.2

1.1

97.69

89.75

u/l

0.37

437

Personality disorders

461

1.50

2.68

1.2

1.1

95.10

82.01

u/l

0.25

383

Alzheimer’s disease, wide definition

340

0.49

2.67

1.1

119.13

90.70

u/l

0.48

250

Covid-19 confirmed case

502

1.48

2.67

1.2

1.1

84.81

88.89

u/l

0.14

398

Other dorsopathies, not elsewhere classified

301

1303

1.22

2.66

1.2

1.1

81.52

86.79

u/l

0.49

245

1036

L02BA Anti-estrogens

358

1.57

2.66

1.2

1.1

85.54

77.55

u/l

0.28

281

Other renal tubulo-interstitial diseases

3.15

2.65

1.1

88.50

84.65

u/l

—

Heartburn

147

1.91

2.65

1.2

1.1

66.66

87.54

u/l

1.33

111

Bipolar affective disorders

296

1.62

2.64

1.2

1.1

109.27

82.37

u/l

0.40

247

Dental pulpitis 3

2.10

2.64

1.2

1.1

67.50

68.69

u/l

0.04

Dorsopathies

311

1308

1.21

2.63

1.1

88.45

86.62

u/l

0.10

249

1040

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

289

1.63

2.62

1.2

77.88

73.04

u/l

0.30

234

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

169

1.84

2.61

1.2

1.1

101.00

83.62

u/l

0.59

127

Mental and behavioural disorders due to alcohol, excluding acute intoxication

117

864

1.35

2.61

1.1

108.21

86.77

u/l

0.74

682

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

127

648

1.35

2.58

1.2

1.1

89.36

84.84

u/l

0.24

103

498

Irregular menses

139

854

1.32

2.57

1.2

1.1

72.53

76.43

u/l

0.47

115

691

Malignant melanoma

260

1.66

2.56

1.3

1.1

84.16

91.78

u/l

0.21

201

Other viral diseases

489

1.47

2.56

1.1

83.88

86.33

u/l

0.10

390

Other inflammation of eyelid

230

1.70

2.55

1.2

1.1

69.73

85.97

u/l

1.08

173

Corneal ulcer

307

1.60

2.54

1.2

1.1

83.85

91.31

u/l

0.34

242

Carpal tunnel syndrome

182

1295

1.27

2.53

1.1

92.11

86.02

u/l

0.30

145

1040

Benign neoplasm: Adrenal gland

108

2.05

2.51

1.1

121.18

88.91

u/l

0.43

Urticaria

567

1.43

2.51

1.2

1.1

96.71

84.08

u/l

0.70

456

115

803

1.35

2.50

1.2

1.1

82.06

89.65

u/l

0.42

609

Erosion of teeth, including avohilmo

359

1.54

2.49

1.2

1.1

85.43

88.00

u/l

0.07

287

Etanercept

2.11

2.48

1.2

1.1

93.08

82.82

u/l

0.13

352

1.54

2.47

1.2

1.1

102.41

91.30

u/l

0.36

257

Umbilical hernia

470

1.47

2.47

1.2

1.1

98.89

92.34

u/l

0.14

367

Acute alcohol intoxication, ICD10

302

1.59

2.46

1.1

100.75

90.41

u/l

0.30

242

Actinic keratosis

106

740

1.36

2.45

1.2

1.1

85.23

89.19

u/l

0.18

553

Bronchitis, not specified as acute or chronic

123

1.96

2.45

1.1

77.33

84.49

u/l

0.15

Melanocytic naevi

463

1.47

2.44

1.3

1.1

75.71

84.02

u/l

0.54

363

Alzheimer’s disease (Late onset)

302

0.48

2.43

1.1

123.25

92.19

u/l

0.42

224

116

860

1.34

2.43

1.1

85.76

86.10

u/l

0.01

690

Other headache syndromes

117

876

1.34

2.43

1.2

1.1

75.43

84.25

u/l

0.90

708

Pre-eclampsia or eclampsia

456

1.47

2.41

1.1

1.2

82.56

78.82

u/l

0.15

376

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

103

2.05

2.41

1.3

1.1

70.36

72.30

u/l

0.06

Other congenital malformations of skin

2.36

2.39

1.0

1.2

115.63

86.14

u/l

—

Fracture at wrist and hand level

606

1.40

2.38

1.1

96.37

90.19

u/l

0.14

485

Other predominantly sexually transmitted diseases, not elsewhere classified

258

1.63

2.38

1.1

91.16

74.46

u/l

0.56

217

Benign neoplasm: Small intestine

2.43

2.37

1.1

83.22

71.05

u/l

—

Squamous cell neoplasms and carcinomas of the skin

175

1.78

2.37

1.2

1.1

101.00

91.17

u/l

0.27

127

Epilepsy

564

1.42

2.36

1.2

1.1

97.28

88.37

u/l

0.35

448

Atopic dermatitis, strict definition

481

1.45

2.36

1.2

1.1

73.88

79.21

u/l

0.35

392

Papillary adenocarcinoma of thyroid gland

2.15

2.35

1.3

1.1

71.31

85.92

u/l

0.61

Skin changes due to chronic exposure to nonionizing radiation

108

760

1.35

2.34

1.2

1.1

84.25

88.75

u/l

0.21

572

Procreative management

526

1.40

2.33

1.2

1.1

76.55

79.97

u/l

0.16

419

Undetermined asthma

206

1.70

2.32

1.1

73.41

94.62

u/l

0.80

153

Migraine

126

815

1.32

2.32

1.2

1.1

76.58

80.18

u/l

0.33

651

Other anxiety disorders

110

728

1.34

2.31

1.2

1.1

104.65

77.52

u/l

0.98

587

Calculus of kidney and ureter

569

1.41

2.30

1.1

87.60

93.87

u/l

0.33

453

Artrosis, including avohilmo

254

1145

1.22

2.30

1.1

87.06

87.99

u/l

0.05

204

917

Spinal stenosis

154

943

1.28

2.29

1.2

1.1

81.83

89.07

u/l

0.43

120

741

Asthma, hospital admission 2, infections

159

1232

1.27

2.29

1.1

87.16

86.59

u/l

0.03

118

985

Asthma-related infections

159

1232

1.27

2.29

1.1

87.16

86.59

u/l

0.03

118

985

Type1 diabetes, definitions combined, early onset

2.18

2.28

1.2

1.1

68.17

79.28

u/l

—

Antenatal screening

269

0.56

2.28

1.0

1.1

80.92

78.31

u/l

0.10

217

Diseases of middle ear and mastoid

143

910

1.29

2.25

1.2

1.1

97.34

84.47

u/l

0.51

125

724

Obesity related asthma

699

1.36

2.24

1.1

74.08

88.57

u/l

1.74

559

Other/unspecified synovitis and tenosynovitis

201

1.70

2.24

1.1

129.11

89.46

u/l

0.50

158

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

171

1.76

2.24

1.1

80.58

82.99

u/l

0.06

122

Benign neoplasm of eye and adnexa

149

1.82

2.24

1.0

1.1

103.29

82.71

u/l

0.50

109

Malignant neoplasm of thyroid gland

121

1.91

2.20

1.3

1.1

71.59

82.56

u/l

0.53

Symptoms and signs involving speech and voice

693

1.36

2.20

1.1

77.99

86.82

u/l

0.72

548

Urolithiasis

625

1.38

2.19

1.1

85.99

92.32

u/l

0.36

496

Alcohol use disorder, ICD-based

107

805

1.33

2.19

1.1

110.93

86.08

u/l

0.80

635

Disorders of adult personality and behaviour

492

1.42

2.17

1.2

1.1

94.58

82.38

u/l

0.23

410

Schizophrenia or delusion, excluding more controls

513

1.41

2.16

1.2

1.1

75.41

82.88

u/l

0.49

422

Early onset COPD

451

1.44

2.16

1.2

1.1

93.05

93.70

u/l

0.02

360

Allergic contact dermatitis

234

1.63

2.16

1.2

1.1

85.55

76.02

u/l

0.46

187

Conjunctivitis

204

1450

1.23

2.15

1.2

1.1

82.21

85.80

u/l

0.26

174

1156

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

2.17

2.14

1.1

106.45

89.00

u/l

0.28

Obsessive-compulsive disorder

2.17

2.14

1.1

77.40

80.87

u/l

—

Sulfonylureas

102

608

1.34

2.14

1.1

98.12

88.94

u/l

0.35

456

Spontaneous rupture of synovium and tendon

137

1.83

2.13

1.0

1.1

101.42

84.80

u/l

0.34

112

Benign neoplasm: Skin of other and unspecified parts of face

159

1.77

2.13

1.1

62.43

78.74

u/l

0.92

116

Benign neoplasm of other and unspecified endocrine glands

228

1.63

2.10

1.2

1.1

99.63

88.21

u/l

0.22

174

Seborrhoeic keratosis

429

1.45

2.10

1.2

1.1

78.29

86.87

u/l

0.36

323

Pre-eclampsia or poor fetal growth

612

1.37

2.09

1.2

1.1

81.14

76.72

u/l

0.23

497

Restless leg syndrome

213

1.65

2.09

1.0

1.1

70.35

82.55

u/l

0.78

165

Nonorganic sleeping disorders, excluding more controls

260

1.58

2.08

1.1

105.01

84.94

u/l

0.44

214

Pollen allergy

265

1.57

2.08

1.1

78.33

75.82

u/l

0.11

219

N06DA Anticholinesterases

502

0.64

2.07

1.0

1.1

93.83

91.66

u/l

0.05

369

Use of anticholinesterases

502

0.64

2.07

1.0

1.1

93.83

91.66

u/l

0.05

369

Diplopia

222

1.63

2.05

1.2

1.1

79.04

89.71

u/l

0.47

170

Other bacterial agents as the cause of diseases classified to other chapters

4.05

2.04

1.5

1.1

99.83

99.81

u/l

—

Acute laryngitis and tracheitis

137

1.80

2.03

1.1

87.72

74.59

u/l

0.20

117

Other intervertebral disc disorders

243

1237

1.20

2.03

1.2

1.1

79.45

87.45

u/l

0.84

196

990

Myocardial infarction, with ST-elevation

286

1.54

2.02

1.0

1.1

94.41

98.99

u/l

0.14

219

Other hammer toe(s) (acquired)

336

1.48

2.01

1.1

84.57

83.93

u/l

0.03

258

Disorders of breast

147

1082

1.26

2.01

1.1

74.42

80.92

u/l

0.88

113

878

Benign neoplasm: Small intestine

2.23

2.01

1.1

83.22

82.45

u/l

—

Other bursopathies

239

1.59

2.01

1.3

1.1

68.06

87.53

u/l

1.33

183

Parodontitis, under 40 years

2.05

2.01

1.3

1.2

77.73

75.69

u/l

0.07

Malignant neoplasm of bladder

1.96

2.00

1.2

1.1

79.43

102.83

u/l

0.64

Asthma-related pneumonia

696

1.34

1.99

1.1

90.95

88.92

u/l

0.08

540

Temporomandibular joint disorders, including avohilmo

112

861

1.30

1.98

1.2

1.1

89.96

81.14

u/l

0.40

693

Amyloidosis, other/unspecified

3.36

1.97

1.0

86.29

103.67

u/l

—

Personal history of other diseases and conditions

133

1.80

1.96

1.2

1.1

74.21

76.98

u/l

0.06

110

Glaucoma

161

1138

1.24

1.95

1.2

1.1

82.31

89.08

u/l

0.64

114

903

Parodontitis, under 40 years, or operation codes

2.03

1.95

1.3

1.2

77.73

76.39

u/l

0.04

Generalized anxiety disorder

202

1.64

1.94

1.1

71.80

72.97

u/l

0.05

173

Asthma, hospital admissions 3, pneumonia

699

1.33

1.94

1.1

90.95

88.75

u/l

0.09

543

Asthma-related pneumonia or sepsis

699

1.33

1.94

1.1

90.95

88.75

u/l

0.09

543

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

139

1080

1.26

1.94

1.1

79.40

87.70

u/l

0.38

114

860

Persistent mood disorders

354

1.47

1.94

1.2

1.1

75.33

89.52

u/l

0.79

279

Use of disulfiram, acamprosate or naltrexone

127

1.82

1.93

1.0

1.1

67.28

101.33

u/l

1.73

106

Transient ischemic attack

143

942

1.26

1.93

1.1

97.01

85.10

u/l

0.48

103

743

Panic disorder

203

1.63

1.91

1.1

68.29

71.69

u/l

0.15

174

Dementia

633

0.72

1.91

1.1

76.82

91.92

u/l

1.01

471

Parodontitis, under 40 years and operation codes

2.06

1.90

1.3

1.2

72.40

75.73

u/l

—

Parodontitis, operation under 40 years and operation codes

2.06

1.90

1.3

1.2

72.40

75.73

u/l

—

Use of pramipexole

439

1.42

1.89

1.1

76.56

89.25

u/l

0.84

340

Phlebitis and thrombophlebitis (not including DVT)

456

1.41

1.88

1.2

1.1

100.20

86.63

u/l

0.41

355

Colonic or urogenital fistula

532

1.37

1.88

1.1

81.71

90.39

u/l

0.47

416

Excessive, frequent and irregular menstruation

112

478

1.30

1.88

1.2

1.1

69.53

81.11

u/l

1.58

376

Migraine, single triptan purchase ok & required. ICD-code if available is included

216

1215

1.20

1.87

1.1

80.60

85.38

u/l

0.39

177

981

Triptan medication for migraine, single purchase ok

216

1215

1.20

1.87

1.1

80.60

85.38

u/l

0.39

177

981

Asthma (diagnoses ohter than nonallergic)

241

1735

1.19

1.87

1.1

81.17

86.25

u/l

0.56

186

1385

Acute otitis externa, noninfective

2.88

1.86

1.4

1.1

64.75

89.65

u/l

—

Hodgkin lymphoma

2.66

1.86

1.1

126.22

68.04

u/l

—

Retinal detachments and breaks

714

1.32

1.86

1.2

1.1

82.29

85.91

u/l

0.15

552

Unspecified mental disorder

105

810

1.30

1.85

1.2

1.1

74.30

87.18

u/l

1.34

668

Wet age-related macular degeneration

279

1.52

1.85

1.0

1.1

97.16

93.56

u/l

0.11

205

Injury of eye and orbit

213

1.60

1.84

1.1

151.77

90.65

u/l

0.68

169

Other autoimmune haemolytic anaemias

3.57

1.84

1.2

1.1

120.50

103.64

u/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

510

1.37

1.82

1.1

66.98

84.02

u/l

1.81

417

Benign neoplasm: Rectum

286

1.51

1.81

1.2

1.1

74.46

84.17

u/l

0.56

219

Cardiodefibrillation

742

1.31

1.81

1.1

96.09

93.24

u/l

0.11

574

Peritonsillar abscess

335

1.46

1.80

1.1

71.43

87.96

u/l

1.19

272

Infective bursitis

2.58

1.80

1.4

1.2

68.89

74.08

u/l

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

2.58

1.80

1.1

103.11

86.38

u/l

—

Other disorders of the musculoskeletal system and connective tissue

263

1.52

1.78

1.3

1.1

98.24

87.65

u/l

0.47

198

Vasomotor and allergic rhinitis

743

1.30

1.77

1.1

78.06

83.99

u/l

0.32

594

Any dementia

555

0.71

1.77

1.1

92.45

u/l

0.00

416

Nontoxic single thyroid nodule

131

1.76

1.77

1.1

1.2

60.75

83.28

u/l

1.51

100

Other blood glucose lowering drugs, excl. Insulins

312

1.48

1.77

1.0

1.1

79.05

86.34

u/l

0.30

234

Visual disturbances and blindness

136

1091

1.25

1.77

1.2

1.1

92.11

86.17

u/l

0.21

106

875

Valvular operations

200

1.60

1.76

1.2

1.1

112.81

89.28

u/l

0.78

157

Fracture of shoulder and upper arm

711

1.31

1.76

1.2

1.1

104.08

85.65

u/l

0.60

552

Delirium, not induced by alcohol and other psychoactive substances

169

1.66

1.76

1.2

1.1

67.23

93.52

u/l

1.57

130

Benign neoplasm: Adrenal gland

124

1.78

1.76

1.1

121.18

79.53

u/l

0.63

Infection due to other mycobacteria

3.36

1.75

1.2

1.1

57.17

62.19

u/l

—

Pulmonary oedema

3.35

1.75

1.5

1.1

65.33

102.75

u/l

—

Other abnormal immunological findings in serum

2.68

1.72

1.1

1.0

101.00

82.65

u/l

—

Paroxysmal tachycardia

320

1.43

1.72

1.1

88.41

73.26

u/l

1.07

268

Amputation of thigh

2.93

1.72

1.3

1.1

69.29

123.94

u/l

—

Delivery, wide proxy

423

0.72

1.68

1.2

1.1

67.51

88.93

u/l

1.77

325

Other specified disorders of external ear

2.19

1.67

1.1

174.44

82.02

u/l

0.51

Behavioural syndromes associated with physiological disturbances and physical factors

535

1.35

1.67

1.1

88.57

84.45

u/l

0.12

427

Alcohol abuse, main dg

235

1.53

1.67

1.1

99.67

93.48

u/l

0.13

187

Superficial injury of abdomen, lower back and pelvis

227

1.54

1.67

1.1

70.45

88.11

u/l

0.93

176

Kela-code for severe mental illness

718

1.30

1.67

1.1

76.15

87.52

u/l

0.96

589

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

144

1153

1.23

1.65

1.2

1.1

82.48

83.14

u/l

0.04

124

929

Fracture of skull and facial bones

334

1.44

1.64

1.2

1.1

103.16

83.68

u/l

0.78

266

Superficial injury of forearm

127

1.74

1.63

1.2

1.1

62.91

83.94

u/l

1.11

100

Unspecified chronic bronchitis

2.25

1.63

1.3

1.1

87.17

75.78

u/l

—

Unspecified fall

123

979

1.25

1.62

1.2

1.1

97.27

88.00

u/l

0.36

108

775

Colorectal adenocarcinoma

352

1.42

1.61

1.1

82.23

89.08

u/l

0.29

265

Other female pelvic inflammatory diseases

344

1.43

1.61

1.2

64.58

77.56

u/l

1.19

267

Arterial embolism and thrombosis of lower extremity artery

2.33

1.60

1.1

1.2

140.50

87.38

u/l

—

Respiratory conditions due to other external agents

2.71

1.58

1.6

1.1

62.57

90.90

u/l

—

Benign neoplasm of eye and adnexa

167

1.62

1.58

1.0

1.1

103.29

82.57

u/l

0.54

129

Congenital malformations of the circulatory system

200

1.55

1.57

1.2

1.1

70.78

86.93

u/l

1.07

160

Colon adenocarcinoma

191

1.57

1.56

1.1

80.58

87.73

u/l

0.18

140

Colorectal cancer

439

1.37

1.56

1.1

87.70

95.54

u/l

0.33

331

Intracerebral haemorrhage

191

1.57

1.56

1.3

1.1

108.19

80.69

u/l

0.46

148

Superficial injury of wrist and hand

313

1.44

1.56

1.1

85.26

89.01

u/l

0.12

258

COPD

121

802

1.25

1.55

1.2

1.1

100.35

89.53

u/l

0.59

620

Cardiomyopathy

264

1.48

1.55

1.1

82.55

91.12

u/l

0.37

202

Polyuria

389

1.39

1.55

1.1

67.79

87.68

u/l

1.85

291

Extrapyramidal and movement disorders

762

1.27

1.54

1.1

73.45

88.84

u/l

1.85

595

Other symptoms and signs involving cognitive functions and awareness

120

906

1.24

1.54

1.1

104.06

87.04

u/l

0.57

716

Other coagulation defects

107

1.78

1.54

1.2

1.1

118.91

84.32

u/l

0.36

Postmenopausal atrophic vaginitis

386

1.31

1.54

1.1

78.65

84.20

u/l

0.35

301

Sleep disorders

364

1.40

1.54

1.1

97.75

88.31

u/l

0.22

288

Other chronic obstructive pulmonary disease

117

780

1.25

1.53

1.2

1.1

93.12

89.88

u/l

0.18

600

Other condition

216

1.53

1.2

1.1

138.84

83.49

u/l

0.52

165

Allergic conjunctivitis

150

1219

1.21

1.53

1.2

1.1

81.15

82.47

u/l

0.08

129

978

Vitiligo

3.36

1.52

1.2

1.1

66.40

116.01

u/l

—

Coxarthrosis, primary, with hip surgery

130

1003

1.23

1.52

1.1

78.21

87.07

u/l

0.55

107

779

Benign neoplasm: Rectum, anus and anal canal

383

1.39

1.50

1.2

1.1

78.62

89.43

u/l

0.70

297

Haemorrhage in early pregnancy

616

0.71

1.49

1.1

80.88

77.64

u/l

0.09

503

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

234

1.50

1.48

1.2

1.1

80.03

84.75

u/l

0.20

176

Hyperfunction of pituitary gland

2.01

1.48

1.2

61.75

92.23

u/l

—

Malignant neoplasm of colon

259

1.47

1.1

89.59

89.80

u/l

0.01

193

Diseases of male genital organs

115

464

1.25

1.47

1.1

89.55

99.52

u/l

0.33

372

Synovial cyst of popliteal space [Baker]

117

1.71

1.45

1.3

1.2

69.59

77.75

u/l

0.33

Benign neoplasm: Sigmoid colon

352

1.39

1.44

1.3

1.1

89.15

90.10

u/l

0.03

272

Donors of organs and tissues

2.75

1.44

1.2

1.1

104.00

122.65

u/l

—

Haemangioma and lymphangioma, any site

125

1.68

1.43

1.0

1.1

87.00

77.53

u/l

0.33

Mixed conductive and sensorineural hearing loss

212

1.51

1.43

1.2

1.1

63.12

89.70

u/l

1.59

156

Rash and other nonspecific skin eruption

172

1.57

1.42

1.2

1.1

59.97

78.35

u/l

1.47

132

Acetic acid derivatives and related substances

301

1.32

1.42

1.1

1.2

100.43

90.05

u/l

0.27

231

Malignant neoplasm of digestive organs

760

1.26

1.41

1.1

102.42

89.22

u/l

0.59

574

Nummular dermatitis

118

1.70

1.41

1.2

1.1

86.65

93.33

u/l

0.16

Other disorders of breast

254

1.46

1.40

1.1

1.2

78.80

75.69

u/l

0.15

198

Toxic effects of substances chiefly nonmedicinal as to source

165

1.58

1.40

1.2

1.1

124.35

80.34

u/l

0.39

132

Insomnia

246

1.47

1.39

1.1

101.89

79.54

u/l

0.45

194

Heterophoria

111

1.72

1.39

1.1

79.84

85.33

u/l

0.14

Ganglion

407

1.35

1.37

1.1

80.97

84.64

u/l

0.17

328

Other arthrosis

140

829

1.21

1.37

1.1

86.27

87.59

u/l

0.06

116

657

Asthma, including avohilmo

331

1700

1.13

1.37

1.1

80.13

86.42

u/l

0.86

256

1363

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

2.62

1.37

1.0

1.1

169.00

80.94

u/l

—

Fall on and from stairs and steps

485

1.32

1.36

1.1

84.93

87.62

u/l

0.14

381

Other nonscarring hair loss

2.97

1.36

1.0

1.3

156.60

96.83

u/l

—

Phakomatoses, not elsewhere classified

2.96

1.36

1.2

1.1

152.44

114.15

u/l

—

Leiomyoma of uterus

192

929

1.18

1.34

1.2

1.1

80.63

80.77

u/l

0.01

157

742

Hodgkin lymphoma, hilmo

2.15

1.34

1.1

126.22

80.18

u/l

—

Nonsuppurative otitis media

279

1.40

1.33

1.2

1.1

107.38

76.40

u/l

0.57

217

Focal epilepsy, strict definition

324

1.39

1.33

1.2

1.1

104.43

86.82

u/l

0.56

252

Injuries to the shoulder and upper arm

225

1634

1.15

1.33

1.2

1.1

95.68

85.99

u/l

0.54

180

1298

Emotionally unstable personality disorder

168

1.55

1.31

1.4

1.1

69.42

81.11

u/l

0.74

145

Bullous pemphigoid

2.51

1.30

1.0

1.1

70.00

101.39

u/l

—

Any dementia, excluding more controls

500

0.75

1.30

1.1

85.50

89.43

u/l

0.14

375

Rare circulating lymphoid malignancy

2.10

1.30

1.1

103.11

85.97

u/l

—

Schizophrenia, schizotypal and delusional disorders

577

1.28

1.30

1.2

1.1

74.38

84.63

u/l

0.76

464

Use of donepezil

307

0.63

1.30

1.0

1.1

97.46

90.73

u/l

0.08

227

Amyloidosis

2.37

1.29

1.0

1.1

212.75

83.35

u/l

—

Allergic contact dermatitis due to drugs in contact with skin

2.37

1.29

1.3

1.1

105.00

91.73

u/l

—

Other disorders of bone density and structure

2.36

1.29

1.1

1.0

75.75

97.74

u/l

—

Angina pectoris

159

905

1.19

1.29

1.1

99.44

81.24

u/l

0.79

121

711

Benign neoplasm: Skin of other and unspecified parts of face

185

1.52

1.28

1.1

62.43

88.57

u/l

2.02

137

Coxarthrosis, primary

164

1208

1.18

1.27

1.1

81.44

90.40

u/l

0.61

135

941

Other chronic obstructive pulmonary disease, including avohilmo

140

974

1.20

1.27

1.2

1.1

93.04

88.70

u/l

0.30

113

751

Pericarditis

2.01

1.27

1.3

1.1

104.27

91.09

u/l

0.23

Nontoxic multinodular goitre

413

1.33

1.27

1.1

79.16

86.00

u/l

0.50

318

Injuries to the neck

379

1.35

1.26

1.1

77.05

87.53

u/l

0.53

309

Other enthesopathies

642

1.26

1.2

1.1

74.09

86.93

u/l

0.64

513

Dental caries 2, only avohilmo

198

1346

1.16

1.25

1.1

80.20

84.83

u/l

0.31

158

1092

Coronary artery bypass grafting

386

1.30

1.25

1.2

1.1

121.84

84.81

u/l

0.85

300

Injury, poisoning and certain other consequences of external causes

156

657

1.19

1.25

1.1

77.55

80.79

u/l

0.24

127

515

Benign neoplasm: Tongue

2.23

1.24

1.0

1.1

70.25

65.27

u/l

—

Migraine without aura

329

1.37

1.23

1.1

80.90

77.57

u/l

0.18

272

Schizophrenia or delusion

574

1.27

1.22

1.2

1.1

75.41

84.52

u/l

0.63

461

Ménière disease

180

1.50

1.20

1.1

95.92

82.72

u/l

0.48

131

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.32

1.19

1.0

1.2

105.08

90.90

u/l

—

Bell's palsy

189

1.48

1.18

1.1

75.40

79.46

u/l

0.14

142

Diaphragmatic hernia

783

1.23

1.18

1.1

77.51

87.33

u/l

1.02

605

Poisoning by medicine, drug-induced

0.00

1.16

0.0

1.2

—

89.67

—

Hernia

263

1577

1.13

1.16

1.1

91.32

86.30

u/l

0.32

222

1243

Oral lichen ruber planus wide, hypothyreosis or thyroxin

102

1.67

1.16

1.1

1.2

62.91

74.97

u/l

0.56

Pregnancy hypertension

112

837

1.21

1.16

1.1

1.2

78.33

76.38

u/l

0.12

683

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

195

1.45

1.15

1.2

68.31

77.26

u/l

0.38

162

COPD, early/later onset

117

823

1.20

1.14

1.2

1.1

93.12

90.98

u/l

0.11

634

Anomalies of pupillary function

0.00

1.14

0.0

1.1

—

82.38

—

Hallux rigidus

266

1.39

1.14

1.1

84.00

91.69

u/l

0.30

197

Disorders of ocular muscles, binocular movement, accommodation and refraction

115

951

1.20

1.14

1.1

79.61

84.61

u/l

0.30

765

Other/unspecified dorsalgia

101

828

1.21

1.13

1.2

1.1

79.58

86.61

u/l

0.44

664

COPD, hospital admissions

116

819

1.20

1.12

1.2

1.1

93.12

91.03

u/l

0.11

630

Abnormal findings on diagnostic imaging of central nervous system

1.90

1.12

1.4

1.1

77.05

76.77

u/l

0.01

Nontoxic goitre/thyroid nodule

662

1.24

1.12

1.1

74.67

82.73

u/l

0.88

522

Retained placenta and membranes, without haemorrhage

259

1.39

1.11

1.1

1.2

79.18

78.81

u/l

0.01

212

Adhesive capsulitis of shoulder

336

1.34

1.11

1.3

1.1

68.88

87.56

u/l

1.76

265

Nontraumatic intracranial haemmorrhage

362

1.33

1.10

1.3

1.1

99.94

89.24

u/l

0.24

289

Transport accidents

111

820

1.20

1.10

1.2

1.1

91.52

80.25

u/l

0.56

656

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

125

923

1.19

1.08

1.1

1.2

75.54

78.07

u/l

0.17

102

758

Secondary polycythaemia

2.20

1.08

1.1

1.2

118.50

87.79

u/l

—

Single spontaneous delivery

526

0.81

1.06

1.1

1.2

69.03

87.94

u/l

1.99

408

Other and unspecified nerve root and plexus disorders, also in other diseases

330

1.34

1.06

1.2

1.1

76.75

80.78

u/l

0.24

260

Alzheimer disease, excluding more controls

227

0.68

1.06

1.0

1.1

98.47

85.68

u/l

0.30

172

Cardiomyopathy, other and unspecified

105

1.62

1.06

1.0

1.1

80.38

90.39

u/l

0.25

Post-traumatic wound infection, not elsewhere classified

2.13

1.05

1.0

1.1

110.43

107.19

u/l

—

Congenital malformations of heart and great arteries

180

1.45

1.05

1.2

1.1

83.92

87.24

u/l

0.10

144

Strabismus

488

1.27

1.05

1.1

80.16

86.07

u/l

0.30

385

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

170

1.47

1.04

1.2

1.1

84.24

72.29

u/l

0.49

120

Dental caries 2 and operation codes

195

1357

1.14

1.04

1.1

81.16

84.54

u/l

0.21

157

1102

Focal epilepsy

359

1.31

1.01

1.2

1.1

104.11

88.90

u/l

0.48

286

Agoraphobia

2.01

1.00

1.4

1.1

98.20

86.52

u/l

—

Other disorders of veins

108

909

1.19

0.99

1.1

95.54

84.39

u/l

1.03

736

Alcohol dependence

484

1.26

0.99

1.1

125.66

88.66

u/l

0.67

387

Visual disturbances

118

1002

1.18

0.99

1.2

1.1

95.89

85.90

u/l

0.33

803

Dementia, including avohilmo

673

0.82

0.99

1.1

78.79

91.36

u/l

0.93

496

Hypersomnia

2.18

0.98

1.0

1.1

92.50

121.11

u/l

—

Toxic liver disease

2.18

0.98

1.0

181.40

93.33

u/l

—

Bitten or struck by other mammals

156

1.48

0.98

1.0

1.1

107.97

79.31

u/l

0.54

128

Unspecified acute lower respiratory infection

206

1.41

0.98

1.1

121.23

90.84

u/l

0.43

163

Malignant neoplasm of skin

165

1081

1.15

0.98

1.2

1.1

87.55

86.85

u/l

0.03

135

835

COPD related to multimorbidity

689

1.20

0.97

1.2

1.1

97.32

91.32

u/l

0.33

527

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

0.97

0.0

1.2

—

83.24

—

Other fall from one level to another

344

1.31

0.97

1.1

93.87

93.82

u/l

0.00

276

Complications of genitourinary prosthetic devices, implants and grafts

1.95

0.97

1.6

1.1

72.86

92.08

u/l

—

Other specified/unspecified disorders of bone/cartilage

1.95

0.97

1.0

1.1

64.71

66.00

u/l

—

Mental and behavioural disorders due to opioids

1.80

0.96

1.3

1.1

68.56

90.86

u/l

—

Torsion of testis

0.00

0.96

0.0

1.1

—

77.67

—

Abrasion of teeth

415

1.24

0.96

1.2

1.1

78.16

89.38

u/l

0.69

334

Noninflammatory disorders of female genital tract

114

483

1.19

0.96

1.1

73.81

80.81

u/l

0.59

380

Nonorganic sleeping disorders

310

1.32

0.96

1.1

105.01

84.46

u/l

0.46

248

Retinal detachment with retinal break

224

1.39

0.96

1.1

74.70

88.67

u/l

0.57

168

Deforming dorsopathies

604

1.23

0.95

1.2

1.1

78.89

87.55

u/l

0.67

478

Dental caries 2

198

1375

1.13

0.95

1.1

81.56

84.39

u/l

0.17

158

1115

Lung diseases due to external agents

216

1.39

0.95

1.2

1.1

94.46

93.12

u/l

0.02

165

Other strabismus

389

1.28

0.94

1.1

82.48

81.71

u/l

0.03

309

Delivery

526

0.82

0.94

1.1

1.2

66.28

87.94

u/l

2.66

408

Benign neoplasm of ovary

320

1.31

0.94

1.2

1.1

87.34

74.79

u/l

0.53

247

Other and unspecified tonsillitis

398

1.26

0.93

1.2

1.1

76.22

91.06

u/l

0.78

328

Disorder of the sleep-wake schedule

2.23

0.93

1.3

1.1

56.17

103.18

u/l

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.23

0.93

1.2

1.1

162.83

95.62

u/l

—

Other disorders of eyelid

119

983

1.17

0.93

1.1

75.19

88.57

u/l

1.65

773

Obstructed labour due to malposition and malpresentation of fetus

393

1.27

0.93

1.2

1.1

72.11

79.29

u/l

0.72

328

Non-Hodgkin lymphoma, all

1.74

0.92

1.1

112.28

81.71

u/l

—

Endometriosis of ovary

329

1.31

0.92

1.1

89.65

78.57

u/l

0.75

263

Sequelae of injuries, of poisoning and of other consequences of external causes

436

1.26

0.92

1.1

84.90

86.10

u/l

0.04

346

Other benign neoplasms of connective and other soft tissue

142

1.48

0.92

1.2

1.1

70.53

85.13

u/l

0.59

104

Enthesopathies of lower limb, excluding foot

463

1.25

0.92

1.2

1.1

102.23

88.40

u/l

0.35

368

Rotator cuff syndrome

164

1066

1.14

0.91

1.2

1.1

80.08

88.04

u/l

0.69

137

844

Primary open-angle glaucoma, strict

543

1.23

0.91

1.2

1.1

78.57

89.68

u/l

0.87

415

Acute and transient psychotic disorders

184

1.42

0.91

1.1

70.55

80.54

u/l

0.40

146

Dislocation, sprain and strain of joints and ligaments of elbow

1.60

0.90

1.0

1.1

69.97

77.80

u/l

—

Pregnancy, childbirth and the puerperium

362

0.79

0.90

1.1

1.2

74.81

87.37

u/l

0.70

281

Acidosis

2.08

0.89

1.2

78.17

103.99

u/l

—

Preterm labour and delivery

591

1.22

0.89

1.1

76.73

78.03

u/l

0.07

481

Disturbances of skin sensation

519

1.23

0.89

1.1

79.25

85.23

u/l

0.29

412

Alopecia areata

1.91

0.88

1.0

1.1

82.50

87.71

u/l

—

Myopia

177

1.41

0.88

1.2

1.1

84.97

77.80

u/l

0.11

146

Asthma and allergy, excluding more controls

150

1.45

0.88

1.3

1.1

95.85

74.33

u/l

0.42

118

Benign neoplasm: Vulva

2.01

0.87

1.0

1.1

48.33

51.60

u/l

—

Other benign neoplasms of skin

785

1.19

0.87

1.2

1.1

86.66

85.03

u/l

0.04

614

Pemphigoid

2.01

0.87

1.0

1.1

70.00

92.26

u/l

—

Small cell lung cancer, helper endpoint

2.01

0.87

1.0

1.1

169.00

98.79

u/l

—

Small cell lung cancer

2.01

0.87

1.0

1.1

169.00

98.79

u/l

—

Tonsillectomy and adenotomy

797

0.85

0.87

1.1

75.94

82.57

u/l

0.43

645

Thoracic aortic aneurysm

212

1.37

0.86

1.1

119.88

86.59

u/l

0.71

164

Neuromuscular dysfunction of bladder

153

1.44

0.85

1.2

1.1

84.87

94.20

u/l

0.11

118

Disorders of refraction and accommodation

475

1.24

0.85

1.1

80.32

85.40

u/l

0.17

375

Fibroblastic disorders

468

1.24

0.85

1.1

85.38

95.38

u/l

0.44

362

Chronic sinusitis

109

934

1.17

0.85

1.1

79.34

86.06

u/l

0.51

754

Allergic urticaria

120

1.50

0.85

1.2

1.1

81.09

80.30

u/l

0.02

Other and unspecified erythematous conditions

1.78

0.84

1.0

1.1

91.63

96.23

u/l

—

Spondylosis

146

1097

1.14

0.84

1.2

1.1

84.24

87.91

u/l

0.14

112

873

HSIL lesion of the cervix uteri, vagina or vulva

344

1.28

0.84

1.2

1.1

78.60

75.60

u/l

0.14

285

Oxicams

285

1.24

0.83

1.1

98.16

90.72

u/l

0.18

219

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

153

1098

1.14

0.83

1.1

76.41

81.60

u/l

0.56

120

886

Salpingitis and oophoritis

434

1.25

0.83

1.1

1.2

81.78

79.79

u/l

0.08

349

Blepharochalasis

661

1.20

0.82

1.1

71.59

84.20

u/l

1.19

516

Benign neoplasm: Tongue

1.75

0.82

1.0

1.1

70.25

88.20

u/l

—

Female infertility

407

0.80

0.82

1.2

1.1

88.28

79.05

u/l

0.30

329

Later onset COPD, excluding more controls

289

1.27

0.81

1.2

1.1

94.59

92.76

u/l

0.05

206

Pain and other conditions associated with female genital organs and menstrual cycle

357

1.26

0.81

1.2

1.1

76.78

74.90

u/l

0.10

290

Glaucoma suspect

773

1.18

0.81

1.1

81.46

89.01

u/l

0.50

609

Sciatica+with lumbago

133

1104

1.14

0.81

1.1

81.43

87.60

u/l

0.35

106

886

Female infertility, cervigal, vaginal, other or unspecified origin

395

0.80

1.3

1.1

89.60

75.85

u/l

0.45

321

Benign neoplasm: Rectum

338

1.27

0.80

1.2

1.1

74.46

88.61

u/l

0.96

261

Other bursal cyst

0.00

0.79

0.0

1.1

—

83.78

—

Carcinoma in situ of other and unspecified digestive organs

1.82

0.79

1.0

1.2

54.33

75.10

u/l

—

Melanocytic naevi of upper limb, including shoulder

1.82

0.79

1.0

1.1

80.80

91.53

u/l

—

Melanocytic naevi

564

1.21

0.79

1.3

1.1

75.71

86.46

u/l

0.78

450

Focal epilepsy, mode (most common among epilepsy diagnosis)

312

1.28

0.79

1.2

1.1

103.45

91.10

u/l

0.30

245

Combinations of oral blood glucose lowering drugs

555

1.21

0.79

1.0

1.1

83.85

91.66

u/l

0.43

424

Anankastic personality disorder

1.67

0.78

1.0

1.1

59.83

86.59

u/l

—

Circumscribed brain atrophy

0.00

0.78

0.0

1.1

—

101.79

—

Crowding of teeth, including avohilmo

0.50

0.78

1.2

1.1

59.80

79.49

u/l

—

Aortic aneurysm

377

1.25

0.78

1.1

102.62

87.30

u/l

0.49

287

Trochanteric bursitis

269

1.30

0.77

1.2

1.1

71.00

80.21

u/l

0.53

208

Other and unspecified nonorganic psychotic disorders

287

1.29

0.76

1.2

1.1

74.06

84.39

u/l

0.54

237

Benign neoplasm: Vulva

1.77

0.76

1.0

1.1

48.33

68.87

u/l

—

Degeneration of the brain due to alcohol

1.77

0.76

1.0

1.2

104.00

92.30

u/l

—

Disorders of globe

1.77

0.76

1.0

1.1

57.25

86.96

u/l

—

Blood alcohol or alcohol intoxication level

1.77

0.76

1.3

1.1

116.00

97.70

u/l

—

Chromosomal abnormalities, not elsewhere classified

0.00

0.76

0.0

1.0

—

80.18

—

Other erythematous conditions

1.70

0.75

1.1

90.11

90.97

u/l

—

Other disorders of thyroid

2.09

0.74

2.0

1.1

43.80

66.36

u/l

—

Basal cell carcinoma

143

1008

1.13

0.73

1.2

1.1

88.57

88.12

u/l

0.02

114

776

Hydrocele

184

1.36

0.73

1.1

93.72

107.01

u/l

0.30

147

Primary open-angle glaucoma

662

1.18

0.73

1.2

1.1

77.54

89.79

u/l

1.21

507

Monoamine oxidase A inhibitors

219

1.33

0.73

1.1

1.2

73.88

90.53

u/l

0.91

172

Dislocation, sprain and strain of joints and ligaments at neck level

219

1.33

0.73

1.0

1.1

87.95

76.91

u/l

0.33

183

Acute alcohol intoxication

433

1.22

0.72

1.1

97.33

88.81

u/l

0.26

349

Propionic acid derivatives

316

1.19

0.72

1.1

92.22

87.67

u/l

0.15

244

Cervical disc disorders

840

0.84

0.72

1.1

82.71

85.88

u/l

0.17

667

Asthma and allergy

157

1.39

0.72

1.3

1.1

95.85

73.80

u/l

0.43

121

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

1.55

0.72

1.0

1.1

116.76

87.52

u/l

0.32

Allergic rhinitis

556

1.19

0.71

1.1

74.24

78.17

u/l

0.26

452

Atypical facial pain

1.58

0.71

1.3

1.1

70.42

79.54

u/l

0.23

Melanocytic naevi of scalp and neck

1.93

0.70

1.2

1.1

56.60

97.25

u/l

—

Benign neoplasm: Ascending colon

203

1.33

0.70

1.1

84.46

85.80

u/l

0.04

148

All dysplastic lesions of the vagina

1.71

0.70

1.0

1.1

60.71

84.54

u/l

—

Complications of labour and delivery

169

844

1.12

0.69

1.1

71.06

81.01

u/l

1.78

133

684

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

683

1.17

0.69

1.1

80.39

78.43

u/l

0.08

558

Other and unspecified hydrocephalus

1.86

0.68

1.0

1.1

130.60

74.00

u/l

—

Long labour

389

1.21

0.67

1.2

1.1

63.54

76.55

u/l

1.75

318

Unspecified event, undetermined intent

1.63

0.67

1.0

1.1

71.79

91.39

u/l

—

Lumbar disc prolapse

167

1194

1.11

0.67

1.2

1.1

82.54

87.62

u/l

0.32

128

954

Convulsions, not elsewhere classified

343

1.24

0.66

1.0

1.1

89.62

78.06

u/l

0.65

279

Plantar fascial fibromatosis

179

1.34

0.66

1.0

1.1

80.50

80.72

u/l

0.01

142

Basal cell carcinoma, including avohilmo

146

1027

1.12

0.66

1.2

1.1

88.61

87.99

u/l

0.03

117

793

Other malignant neoplasms of skin (=non-melanoma skin cancer)

138

970

1.12

0.66

1.2

1.1

90.58

88.22

u/l

0.11

112

742

Pneumonia derived septicemia

1.59

0.65

1.1

79.86

88.39

u/l

—

Other obstetric conditions, not elsewhere classified

302

1.21

0.64

1.1

1.2

83.63

73.70

u/l

0.74

252

Fenamates

204

1.26

0.64

1.1

1.2

75.78

90.20

u/l

0.87

159

Varicose veins

178

1218

1.10

0.63

1.2

1.1

83.46

86.84

u/l

0.28

129

977

Hallux valgus (acquired)

572

1.15

0.63

1.1

72.80

86.33

u/l

1.54

458

Voice disturbances

561

1.18

0.63

1.1

70.69

85.20

u/l

1.57

437

Benign neoplasm of mouth and pharynx

164

1.34

0.62

1.0

1.1

65.73

88.23

u/l

1.00

125

Viral pneumonia (known virus, not influenza)

1.67

0.61

1.6

1.2

108.20

73.95

u/l

—

Benign neoplasm of major salivary glands

147

1.36

0.61

1.4

1.1

93.30

82.30

u/l

0.25

109

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

1.60

0.61

1.1

94.86

96.59

u/l

—

Scoliosis

130

1.39

0.61

1.2

77.69

81.29

u/l

0.11

103

Localized swelling, mass and lump of skin and subcutaneous tissue

628

1.16

0.61

1.1

89.88

87.68

u/l

0.08

492

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.2

—

84.85

—

Crushing injury of wrist and hand

0.00

0.60

0.0

1.1

—

113.86

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

650

0.88

0.60

1.1

1.2

72.64

76.24

u/l

0.38

532

Chronic rhinitis, nasopharyngitis and pharyngitis

648

1.16

0.59

1.1

68.64

89.24

u/l

3.04

518

Cardiomyopathy (excluding other)

183

1.31

0.59

1.0

1.1

71.94

95.45

u/l

1.34

142

Acute pharyngitis

173

1.32

0.59

1.1

81.62

82.27

u/l

0.02

147

Meniscus derangement

141

867

1.11

0.59

1.1

85.14

87.27

u/l

0.12

105

686

Maternal care for other known or suspected fetal problems

237

1.22

0.59

1.1

1.2

68.86

76.71

u/l

0.65

202

Haemangioma, any site

114

1.41

0.58

1.0

1.1

81.57

76.18

u/l

—

Medical abortion

176

869

1.10

0.58

1.2

1.1

82.29

79.01

u/l

0.29

147

692

Degeneration of nervous system due to alcohol

1.72

0.57

1.0

1.2

104.00

89.29

u/l

—

Thyrotoxicosis with toxic multinodular goitre

106

1.42

0.57

1.2

1.1

81.10

76.72

u/l

—

Haemangioma and lymphangioma, any site

158

1.33

0.57

1.0

1.1

87.00

83.26

u/l

0.11

127

Supervision of high-risk pregnancy

255

0.81

0.57

1.1

73.04

77.12

u/l

0.19

206

Other secondary gonarthrosis

1.48

0.57

1.3

1.1

69.25

75.03

u/l

0.20

Asthma, hospital admissions , main diagnosis only

212

1748

1.09

0.56

1.1

78.02

86.95

u/l

1.18

164

1394

Inguinal hernia

108

816

0.89

0.54

1.1

101.09

90.94

u/l

0.42

623

Conjunctivitis (acute, non atopic)

494

1.17

0.54

1.2

1.1

88.34

87.29

u/l

0.03

386

Cervicocranial syndrome

213

1.27

0.53

1.0

1.1

95.55

81.22

u/l

0.61

165

Malignant neoplasm of eye, brain and central nervous system

1.48

0.53

1.3

1.1

110.11

89.74

u/l

—

Lateral epicondylitis

258

1.24

0.53

1.1

87.70

83.89

u/l

0.06

214

Soft tissue disorders related to use, overuse and pressure

543

1.16

0.53

1.1

107.44

89.68

u/l

0.38

431

Deviated nasal septum

653

0.86

0.53

1.1

79.25

93.58

u/l

1.22

510

Diseases of appendix

189

1584

1.09

0.53

1.1

78.82

86.11

u/l

0.97

152

1271

Other maternal disorders predominantly related to pregnancy

131

911

0.90

0.52

1.2

1.1

77.29

78.93

u/l

0.10

106

739

Tinnitus

451

1.18

0.52

1.2

1.1

76.43

89.26

u/l

1.14

344

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

326

1.21

0.52

1.2

1.1

89.28

74.59

u/l

0.96

243

Malignant neoplasm of corpus uteri

152

1.32

0.52

1.3

1.1

78.25

67.61

u/l

0.52

112

Polypectomy (DHB20)

0.61

0.52

1.0

1.1

54.78

94.27

u/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

423

1.17

0.51

1.2

1.1

89.00

95.36

u/l

0.23

321

Carcinoma in situ of other and unspecified digestive organs

1.50

0.51

1.0

1.2

54.33

92.59

u/l

—

Contact with machinery

161

1.31

0.51

1.1

118.37

107.98

u/l

0.08

128

Dementia in Alzheimer disease

241

0.78

0.51

1.0

1.1

127.60

94.20

u/l

0.60

182

Other/unspecified soft tissue disorders related to use, overuse and pressure

1.47

0.50

1.2

1.0

265.17

75.28

u/l

—

Appendectomy

162

1431

1.09

0.50

1.2

1.1

79.37

85.42

u/l

0.65

125

1167

Allergic asthma (mode), excluding more controls

364

1.19

0.49

1.1

83.25

84.29

u/l

0.03

288

Asthma/COPD (KELA code 203)

244

1603

1.07

0.49

1.1

75.63

85.17

u/l

1.70

195

1288

Pain in thoracic spine

289

1.21

0.48

1.1

70.96

85.95

u/l

0.88

229

Anti-inflammatory and antirheumatic products, non-steroids

316

1.15

0.48

1.1

90.84

87.67

u/l

0.10

244

Effects of foreign body entering through natural orifice

400

1.18

0.48

1.2

1.1

103.81

94.00

u/l

0.14

317

Thyroiditis

128

1.33

0.47

1.1

125.83

78.75

u/l

0.49

105

Caught, crushed, jammed or pinched in or between objects

1.47

0.47

1.1

120.80

89.70

u/l

—

Erosion and ectropion of cervix uteri

1.46

0.47

1.4

1.2

54.57

71.41

u/l

—

COPD, hospital admission 2, with asthma infections

533

1.14

0.46

1.2

1.1

95.30

94.46

u/l

0.03

411

Recurring oral aphthae, including avohilmo

236

1.23

0.46

1.0

1.1

76.10

80.54

u/l

0.13

178

Prolapse and hernia of ovary and fallopian tube

1.45

0.46

1.1

81.43

82.81

u/l

—

Cardiomyopathies, Primary/intrinsic

173

1.27

0.46

1.0

1.1

69.65

95.12

u/l

1.43

134

Unstable angina pectoris

659

1.12

0.46

1.1

89.34

85.10

u/l

0.22

512

Infections of breast associated with childbirth

1.43

0.46

1.0

1.1

65.14

88.76

u/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

430

1.16

0.46

1.1

79.58

85.94

u/l

0.32

327

Other disorders of patella

319

1.19

0.45

1.1

81.88

88.94

u/l

0.33

262

Antepartum haemorrhage, not elsewhere classified

119

0.67

0.45

1.0

1.2

66.25

80.82

u/l

—

103

Female infertility, tubal origin

0.59

0.45

2.0

1.2

152.40

75.22

u/l

—

Lichen planus

255

1.22

0.45

1.1

80.06

78.72

u/l

0.04

193

Maternal care for known or suspected abnormality of pelvic organs

319

0.84

0.45

1.2

74.38

77.16

u/l

0.18

270

Other acute skin changes due to ultraviolet radiation

1.40

0.45

1.1

48.14

84.53

u/l

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

112

1.34

0.44

1.1

259.33

83.09

u/l

—

Pneumococcal septicemia

1.37

0.44

1.1

79.86

87.84

u/l

—

Other spirochaetal diseases

526

1.14

0.43

1.1

80.89

87.31

u/l

0.35

405

Lichen sclerosus et atrophicus

184

1.25

0.43

1.0

1.2

95.50

78.80

u/l

0.72

136

Benign neoplasm: Parotid gland

104

1.35

0.43

1.4

1.1

79.13

84.86

u/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

104

900

0.91

0.43

1.1

1.2

75.78

74.91

u/l

0.06

735

Other specific arthropathies, wide

1.57

0.42

1.6

1.0

99.40

94.16

u/l

—

Carcinoma in situ of skin of trunk

1.57

0.42

1.0

1.2

95.40

94.30

u/l

—

Other specified/unspecified dorsopathies

1.41

0.42

1.0

1.1

118.63

86.24

u/l

—

Use of antiglaucoma preparations and miotics

131

1.30

0.42

1.0

1.1

87.17

79.48

u/l

0.24

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

1.38

0.41

1.4

1.1

131.63

77.27

u/l

—

Lyme disease

519

1.14

0.41

1.1

80.27

87.98

u/l

0.43

398

Carcinoma in situ of breast, lobular

0.00

0.41

0.0

1.1

—

48.90

—

Viral agents as the cause of diseases classified to other chapters

1.52

0.41

1.2

261.34

92.04

u/l

—

Benign neoplasm: Scapula and long bones of upper limb

0.00

0.41

0.0

1.1

—

66.80

—

Other injuries of upper limb, level unspecified

0.00

0.41

0.0

1.1

—

132.58

—

Frostbite

0.00

0.41

0.0

1.1

—

113.98

—

Parkinson's disease, including avohilmo

272

0.81

0.41

1.2

1.1

75.05

88.24

u/l

0.41

207

Injury of nerves at lower leg level

0.00

0.40

0.0

1.1

—

120.67

—

Intracranial and intraspinal abscess and granuloma

0.00

0.40

0.0

1.1

—

78.42

—

Fall on and from ladder

114

1.32

0.40

1.1

84.88

105.13

u/l

—

Bruxism

1.47

0.40

1.0

1.1

46.40

96.87

u/l

—

Injury of intra-abdominal organs

1.47

0.40

1.2

1.1

77.26

86.68

u/l

—

Other disorders of pigmentation

1.33

0.40

1.1

124.00

89.03

u/l

—

Fasciculation

0.00

0.40

0.0

1.1

—

84.34

—

Benign neoplasm of meninges

159

1.26

0.40

1.2

1.1

82.99

80.28

u/l

0.06

113

Malignant neoplasm of larynx

0.00

0.40

0.0

1.1

—

120.17

—

Other benign neoplasm of uterus: Corpus uteri

0.00

0.39

0.0

1.1

—

63.56

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.00

0.39

0.0

1.1

—

114.98

—

Mouth breathing

844

1.10

0.39

1.2

1.1

72.05

90.42

u/l

2.74

676

Anomalies of dental arch relationship, including avohilmo

275

1.18

0.39

1.2

1.1

81.11

76.64

u/l

0.23

223

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

289

1.15

0.38

1.1

1.2

81.25

74.29

u/l

0.42

242

Benign lipomatous neoplasm

633

0.88

0.38

1.1

68.07

89.06

u/l

2.58

496

Erythema multiforme

1.39

0.38

1.2

1.1

76.60

98.70

u/l

—

Migraine without aura and triptan purchases

261

1.19

0.38

1.2

85.53

77.29

u/l

0.44

224

Ectopic pregnancy

409

0.86

0.38

1.1

78.75

77.55

u/l

0.04

343

Retinal vascular disorders

206

1.21

0.37

1.3

1.1

73.56

91.04

u/l

0.78

150

Non-small cell lung cancer, adenocarcinoma

1.33

0.37

1.0

1.1

116.76

87.92

u/l

0.32

Non-small cell lung cancer, adenocarcinoma, helper endpoint

1.33

0.37

1.0

1.1

116.76

87.92

u/l

0.32

Appendicitis, broad definition

184

1576

1.07

0.37

1.2

1.1

78.03

86.19

u/l

1.13

148

1266

Pedestrian injured in transport accident

112

0.71

0.37

1.1

114.25

78.39

u/l

—

Organic, including symptomatic, mental disorders

100

789

0.91

0.37

1.1

72.71

92.29

u/l

2.56

597

Gestational diabetes (for exclusion)

492

0.89

0.37

1.1

1.2

65.92

76.31

u/l

1.71

409

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

544

1.12

0.36

1.2

1.1

104.49

91.06

u/l

0.27

428

Acute appendicitis

172

1519

1.07

0.36

1.1

79.59

85.43

u/l

0.65

136

1222

Melanocytic naevi of upper limb, including shoulder

1.43

0.35

1.0

80.80

97.41

u/l

—

Other abnormal products of conception

451

1.11

0.35

1.1

70.19

74.60

u/l

0.38

380

Excessive vomiting in pregnancy

126

1.27

0.35

1.1

76.45

73.17

u/l

0.14

101

Benign mammary dysplasia

308

0.84

0.34

1.1

83.49

78.11

u/l

0.15

237

Single delivery by forceps and vacuum extractor

162

0.83

0.33

1.3

1.2

75.88

82.73

u/l

0.23

135

Dizziness and giddiness

192

1469

1.06

0.33

1.1

98.25

84.95

u/l

0.71

148

1181

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.31

0.33

1.0

1.1

108.33

102.34

u/l

—

Other enthesopathy of foot (+metatarsalgia)

182

1.21

0.33

1.3

1.1

56.63

78.06

u/l

2.09

144

Abnormal findings on antenatal screening of mother

0.69

0.33

1.2

51.17

83.37

u/l

—

Injury of muscle and tendon at lower leg level

238

1.18

0.32

1.2

1.1

89.43

96.13

u/l

0.17

189

Other obstetric trauma

1.35

0.32

1.0

1.1

61.75

82.42

u/l

—

Benign lipomatous neoplasm

502

1.12

0.32

1.1

68.07

84.29

u/l

1.70

394

Abnormalities of gait and mobility

187

0.80

0.32

1.1

83.98

89.05

u/l

—

144

Spondylolisthesis/Spondylolysis

389

1.13

0.31

1.1

80.86

85.92

u/l

0.25

303

Allergic asthma (mode)

382

1.13

0.31

1.1

83.25

86.01

u/l

0.07

296

Dipeptidyl peptidase 4 (DPP-4) inhibitors

202

1.19

0.31

1.0

1.1

112.32

80.23

u/l

0.76

147

Other benign neoplasms of connective and other soft tissue

175

1.20

0.30

1.2

1.1

70.53

81.69

u/l

0.54

134

Fracture of neck

1.31

0.30

1.2

1.1

70.45

86.85

u/l

0.60

Schizophrenia

259

1.16

0.29

1.1

83.42

88.23

u/l

0.13

207

Pedal cyclist injured in transport accident

388

0.88

0.29

1.2

1.1

104.59

86.68

u/l

0.34

305

Metatarsalgia

167

1.20

0.28

1.3

1.1

58.21

78.24

u/l

1.62

133

Triptan medication for migraine, min. 3 purchases

119

1003

0.94

0.28

1.2

1.1

76.82

78.88

u/l

0.12

101

819

All dysplastic lesions of the cervix uteri, vagina or vulva

561

1.10

0.28

1.1

1.2

81.49

74.48

u/l

0.47

462

Obstructed labour due to maternal pelvic abnormality

365

0.88

0.28

1.2

73.77

81.13

u/l

0.32

295

Dental caries 2 and operation codes, only avohilmo

184

1083

1.05

0.27

1.1

79.20

85.05

u/l

0.40

146

860

Other and unspecified iridocyclitis

1.25

0.27

1.1

49.38

85.17

u/l

—

Benign neoplasm: Ascending colon

233

1.16

0.27

1.1

84.46

93.03

u/l

0.30

175

Retinal vascular occlusion

205

1.17

0.27

1.3

1.1

71.76

91.04

u/l

0.86

150

Other noninflammatory disorders of uterus, except cervix

359

1.10

0.27

1.1

81.13

87.11

u/l

0.29

276

Endometriosis ASRM stages 3,4

481

1.10

0.26

1.1

88.19

77.41

u/l

0.83

386

Coxibs

306

1.10

0.26

1.1

1.2

95.66

89.39

u/l

0.13

236

Medical treatment for female infertility

347

1.12

0.26

1.2

1.1

67.53

75.90

u/l

0.68

294

DVT of lower extremities

367

1.12

0.25

1.2

1.1

93.06

89.37

u/l

0.08

284

Acute appendicitis, no complications

131

1233

1.06

0.25

1.2

1.1

79.67

86.02

u/l

0.55

104

1003

Dental caries 3 and operation codes, only avohilmo

376

1.08

0.25

1.1

79.19

81.39

u/l

0.10

304

Parkinson's disease

256

0.86

0.25

1.2

1.1

75.05

87.46

u/l

0.38

194

Endometriosis of rectovaginal septum and vagina

123

1.22

0.25

1.1

80.80

75.83

u/l

—

Atrophic disorders of skin

264

1.14

0.24

1.0

1.1

95.86

79.79

u/l

0.79

198

Hordeolum and other deep inflammation of eyelid

0.74

0.24

1.7

1.1

77.83

78.50

u/l

—

LSIL lesion of the cervix uteri, vagina or vulva

246

1.14

0.23

1.0

1.2

78.72

77.06

u/l

0.06

204

Enteropathic arthropathies

1.32

0.23

1.0

77.00

97.19

u/l

—

Generalized epilepsy, strict definition

1.32

0.23

1.0

1.1

97.40

104.81

u/l

—

Carcinoma in situ of skin of trunk

1.32

0.23

1.0

1.1

95.40

110.58

u/l

—

Melanocytic naevi of scalp and neck

1.28

0.23

1.2

1.1

56.60

106.93

u/l

—

Other specified disorders of muscle

1.28

0.23

1.4

1.1

71.00

74.40

u/l

—

Parkinson's disease, strict definition

232

0.86

0.22

1.1

77.77

87.98

u/l

0.26

177

Other peripheral vascular diseases

125

1.20

0.22

1.1

75.07

79.35

u/l

0.11

Bacterial pneumoniae

704

1.07

0.22

1.1

77.93

85.88

u/l

0.63

549

Oter anti-inflammatory and antirheumatic agents, non-steroids

269

1.09

0.22

1.1

88.83

92.63

u/l

0.12

205

COPD, hospital admissions 1, only main diagnosis

612

1.07

0.21

1.1

90.63

93.78

u/l

0.14

469

Lichen planus, including avohilmo

372

1.10

0.21

1.1

78.14

84.50

u/l

0.28

284

Palmar fascial fibromatosis [Dupuytren]

286

1.12

0.21

1.2

1.1

75.30

93.78

u/l

1.05

218

Malignant neoplasm of base of tongue

0.00

0.21

0.0

1.2

—

119.85

—

Motorcycle rider injured in noncollision transport accidents

1.19

0.21

1.0

1.2

59.80

94.45

u/l

—

Cicatricial alopecia [scarring hair loss]

0.00

0.21

0.0

1.2

—

53.20

—

Marginal zone B-cell lymphoma

0.00

0.21

0.0

1.2

—

106.67

—

Benign neoplasm: Scapula and long bones of upper limb

0.00

0.21

0.0

1.3

—

49.86

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.23

0.21

1.3

1.1

92.57

84.94

u/l

—

Right side

0.00

0.21

0.0

1.2

—

75.26

—

Hyperprolactinaemia, drug-induced

0.00

0.21

0.0

1.3

—

85.61

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.21

0.0

1.1

—

56.24

—

Other specified and unspecified disorders of lens

0.00

0.21

0.0

1.2

—

72.50

—

Melanoma in situ of other and unspecified parts of face

0.00

0.21

0.0

1.2

—

88.75

—

Benign neoplasm of mouth and pharynx

192

1.15

0.20

1.0

1.1

65.73

84.24

u/l

0.87

145

Embedded and impacted teeth

276

0.89

0.20

1.0

1.2

70.96

73.45

u/l

0.08

224

Carcinoma in situ of uteri, other/unspecified

0.00

0.20

0.0

1.1

—

56.21

—

Correction of physiology of bite - very demanding therapy visit

1.23

0.20

1.0

1.1

60.67

89.12

u/l

—

Malignant neoplasm of brain

1.23

0.20

1.3

1.1

143.00

88.41

u/l

—

Orchitis and epididymitis

136

1.18

0.20

1.0

1.1

96.73

110.05

u/l

0.19

110

Superficial injury of head

374

1.10

0.20

1.1

96.78

82.09

u/l

0.34

293

Benign neoplasm of major salivary glands

174

1.15

0.19

1.4

1.1

93.30

86.21

u/l

0.15

131

Impingement syndrome of shoulder

520

1.08

0.19

1.1

99.73

90.76

u/l

0.15

418

Hydrocephalus

118

1.19

0.19

1.1

104.43

89.61

u/l

—

Memory loss

154

0.84

0.19

1.2

1.1

85.55

83.52

u/l

—

117

Melanocytic naevi of other and unspecified parts of face

1.24

0.18

1.3

1.1

99.30

76.01

u/l

—

Other and unspecified effects of external causes

498

0.92

0.18

1.1

120.48

84.45

u/l

0.96

397

Transient global amnesia

174

0.86

0.17

1.1

78.53

82.33

u/l

—

128

Other/unspecified enthesopathies of lower limb, excluding foot

119

1.18

0.17

1.1

92.00

85.37

u/l

—

100

Redundant prepuce, phimosis and paraphimosis

289

1.10

0.17

1.1

75.95

107.54

u/l

2.09

237

Persistent delusional disorders

119

1.18

0.17

1.1

46.90

80.93

u/l

—

All dysplastic lesions of the cervix uteri

485

0.93

0.17

1.1

77.54

74.80

u/l

0.12

402

Cervicobrachial syndrome

486

0.93

0.17

1.1

70.00

87.85

u/l

1.47

389

Pregnancy with abortive outcome

174

876

1.04

0.17

1.2

1.1

75.12

79.01

u/l

0.42

138

696

Glaucoma, exfoliation

186

1.13

0.16

1.3

1.1

76.57

90.27

u/l

0.62

139

Abnormal involuntary movements

215

1.12

0.16

1.2

1.1

75.95

89.14

u/l

0.42

174

Desensitization to allergens

1.13

0.16

1.0

1.1

59.00

89.45

u/l

—

Premature rupture of membranes

265

0.91

0.16

1.1

1.2

64.92

75.65

u/l

1.09

224

Prolonged pregnancy

205

0.89

0.16

1.1

1.2

60.55

77.14

u/l

1.15

172

Primary angle-closure glaucoma

0.77

0.15

1.2

1.1

59.00

79.68

u/l

—

Non-allergic asthma (mode), excluding more controls

319

1.09

0.15

1.1

76.50

85.62

u/l

0.38

239

Other degenerative diseases of the nervous system

397

0.94

0.15

1.1

90.70

84.52

u/l

0.23

314

Dysplasia of cervi uteri

377

1.07

0.14

1.1

81.40

73.98

u/l

0.46

305

Additional codes for the location of defect, injury or illness

1.19

0.14

1.0

1.1

182.10

84.92

u/l

—

Crushed, pushed or stepped on by crowd or human stampede

0.81

0.13

1.0

1.1

56.09

82.28

u/l

—

Acute appendicitis, with complications

383

1.07

0.13

1.1

79.30

90.61

u/l

0.82

307

Status post-ami

0.82

0.13

1.0

103.80

92.11

u/l

—

Dental caries 1 and operation codes, only avohilmo

325

1.05

0.12

1.1

74.25

82.26

u/l

0.44

266

Glucosamine medication

127

982

1.03

0.11

1.1

91.99

90.01

u/l

0.08

106

767

Subarachnoid haemorrhage

172

1.11

0.11

1.3

1.1

81.93

82.61

u/l

0.02

133

Care involving use of rehabilitation procedures

138

1274

1.03

0.10

1.2

1.1

78.63

83.74

u/l

0.46

100

1020

Haemangioma, any site

144

1.11

0.10

1.0

1.1

81.57

83.33

u/l

—

115

Provisional assignment of new diseases of uncertain etiology

889

1.03

0.10

1.2

1.1

84.56

83.59

u/l

0.04

703

Benign neoplasm of other and unspecified sites

1.14

0.10

1.4

1.1

276.86

69.69

u/l

—

Specific development disorders of scholastic skills

1.12

0.10

1.0

72.34

72.72

u/l

—

Migraine with aura

412

0.95

0.09

1.2

1.1

77.94

82.32

u/l

0.22

337

Other disorders of male genital organs

1.09

0.09

1.0

1.2

68.60

97.71

u/l

—

Meralgia paraesthetica

1.04

0.09

1.4

1.2

94.40

79.67

u/l

—

Persons encountering health services in circumstances related to reproduction

127

884

0.97

0.09

1.1

1.2

77.01

84.63

u/l

0.79

104

715

Codes for special purposes

891

1.03

0.09

1.2

1.1

84.56

83.60

u/l

0.04

705

Injury of muscle and tendon at shoulder and upper arm level

736

0.96

0.09

1.1

79.43

89.05

u/l

0.68

569

Chronic diseases of tonsils and adenoids

192

1190

1.02

0.09

1.1

74.21

87.55

u/l

2.45

165

955

Vertical strabismus

1.07

0.08

1.0

1.2

104.13

95.64

u/l

—

Separation of retinal layers (serosa)

1.05

0.08

1.0

1.1

67.42

88.30

u/l

—

Benign neoplasm of ovary

400

1.05

0.08

1.2

1.1

87.34

75.18

u/l

0.50

312

Radiculopathy

328

0.94

0.08

1.1

85.41

89.07

u/l

0.13

252

Parkinson's disease, excluding more controls

230

0.93

0.08

1.2

1.1

75.05

85.53

u/l

0.32

176

Generalized epilepsy

1.08

0.08

1.0

1.1

97.70

92.14

u/l

—

Malignant neoplasm of head and neck

123

0.89

0.08

1.2

1.1

141.91

89.73

u/l

0.56

Other symptoms and signs involving the urinary system

156

1.09

0.08

1.3

1.1

129.17

88.14

u/l

0.36

122

Malignant neoplasm of mesothelium and soft tissue

1.04

0.08

1.1

147.79

78.96

u/l

—

Parkinson's disease, strict definition, excluding more controls

211

0.93

0.08

1.1

77.77

85.38

u/l

0.19

164

Burns and corrosions

205

1.07

0.07

1.1

89.47

95.19

u/l

0.15

162

Gestational [pregnancy-induced] hypertension

489

1.04

0.07

1.1

1.2

71.41

76.30

u/l

0.40

398

Other acquired deformities of musculoskeletal system and connective tissue

0.81

0.07

1.2

1.1

138.63

82.79

u/l

—

Aneurysms, operations, SAH

314

1.05

0.07

1.2

1.1

84.69

87.27

u/l

0.09

245

Bacterial pneumonia (organism specified)

845

1.02

0.06

1.1

85.06

88.26

u/l

0.18

657

Ill-defined and unknown causes of mortality

1.11

0.05

1.3

1.1

63.80

91.65

u/l

—

Other menopausal disorders

387

1.03

0.05

1.2

1.1

84.56

82.45

u/l

0.07

306

Other appendicitis

149

1.07

0.05

1.3

1.1

58.50

82.48

u/l

1.94

123

Contraceptive management

654

1.02

0.05

1.2

1.1

72.27

83.29

u/l

1.21

536

malignant neoplasm of female genital organs

323

0.96

0.05

1.2

1.1

81.72

79.01

u/l

0.13

249

Endometriosis

462

0.98

0.04

1.1

84.90

81.39

u/l

0.21

363

Diabetes mellitus in pregnancy

386

1.02

0.04

1.2

1.1

77.66

76.28

u/l

0.07

323

Benign neoplasm of meninges

190

1.05

0.04

1.2

1.1

82.99

75.74

u/l

0.18

142

Labour and delivery complicated by fetal stress [distress]

228

0.97

0.03

1.3

1.2

61.40

77.49

u/l

1.35

191

Single delivery by caesarean section

221

0.97

0.03

1.1

1.2

74.32

83.57

u/l

0.83

180

Maternal care for known or suspected malpresentation of fetus

208

1.04

0.03

1.1

1.2

82.82

77.73

u/l

0.21

178

Dislocation, sprain and strain of joints and ligaments of knee

131

1232

0.99

0.03

1.1

77.26

83.90

u/l

0.77

113

985

Melanocytic naevi of other and unspecified parts of face

1.09

0.03

1.3

1.1

99.30

85.24

u/l

—

Subjective visual disturbances

479

1.02

0.03

1.2

1.1

87.31

85.13

u/l

0.08

373

Spontaneous abortion

108

743

0.99

0.02

1.1

86.23

78.07

u/l

0.78

603

Unspecified lump in breast

329

0.97

0.02

1.2

1.1

67.03

75.86

u/l

0.62

255

Complications predominantly related to the puerperium

560

1.02

0.02

1.1

87.08

77.43

u/l

0.44

456

Later onset COPD

424

0.98

0.02

1.2

1.1

94.70

94.18

u/l

0.02

319

Non-allergic asthma (mode)

339

1.02

0.01

1.1

76.50

88.34

u/l

0.50

249

Amiodarone users

154

1.04

0.00

1.1

72.75

97.13

u/l

—

118

Deep endometriosis

166

0.96

0.00

1.1

85.45

71.05

u/l

0.66

132

Other puerperal infections

1.02

0.00

1.4

1.1

63.10

79.84

u/l

—

Chronic suppurative otitis media, including avohilmo

118

1.02

0.00

1.1

169.14

81.84

u/l

0.50

Lesion of ulnar nerve

232

0.99

0.00

1.1

67.09

87.94

u/l

1.67

180

Use of levodopa decarboxylase inhibitor

215

1.02

0.00

1.1

75.02

88.28

u/l

0.43

160

Adverse effects, not elsewhere classified

352

0.99

0.00

1.1

105.20

76.79

u/l

0.97

280

Bacterial pneumonia, not elsewhere classified

667

0.99

0.00

1.1

74.16

87.01

u/l

1.21

518

Maternal care for other conditions predominantly related to pregnancy

390

0.99

0.00

1.1

74.86

77.44

u/l

0.14

327

Alcohol withdrawal state with delirium

1.03

0.00

1.2

1.1

75.79

89.32

u/l

—

Erectile dysfunction

117

1.03

0.00

1.0

1.1

83.46

114.96

u/l

—

Benign neoplasm: Parotid gland

137

1.02

0.00

1.4

1.1

79.13

83.04

u/l

—

105

Benign neoplasm: salivary glands, exclude unknown (D119)

157

1.02

0.00

1.4

1.1

84.72

86.93

u/l

—

120

Chronic suppurative otitis media

104

0.96

0.00

1.1

190.80

82.44

u/l

—

Other congenital malformations of male genital organs

0.00

0.0

1.0

—

40.00

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

0.0

1.0

—

94.08

—

Other diseases of gallbladder

0.88

0.00

1.2

118.17

82.02

u/l

—

Oral leukoplakia and related diseases

0.94

0.00

1.4

1.1

76.88

77.36

u/l

—

Other orthopaedic follow-up care

0.93

0.00

1.7

1.1

102.71

76.54

u/l

—

Eustachian salpingitis and obstruction

0.92

0.00

1.1

115.11

81.95

u/l

—

Other inflammation of vagina/vulva

1.02

0.00

1.0

1.1

56.60

79.11

u/l

—

Ptosis of eyelid

190

1.00

0.00

1.1

84.64

89.64

u/l

0.15

141

Slow fetal growth and fetal malnutrition

0.00

0.0

1.0

—

54.58

—

Hypospadias

0.00

0.0

1.0

—

37.40

—

Benign neoplasm of other and unspecified sites

0.96

0.00

1.4

1.1

276.86

85.21

u/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS